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Abstract  
 Growth modification of the lower jaw during mandibular forward positioning is a 
successful example for bone remodeling in response to a change in biophysical environment. 
This remodeling occurs by expression of cells’ endogenous regulatory factors in the 
Mandibular Condylar Cartilage (MCC) and the Glenoid Fossa (GF) through an Endochondral 
Ossification (EO) and Intramembranous Ossification (IO) process. Fibroblast Growth Factor 
(FGF) is one factor regulating mesenchyme and chondrocyte proliferation in the MCC 
adaptive remodeling. FGF signaling results in a decrease in chondrocyte proliferation and 
acceleration in the hypertrophic differentiation in chondrocytes. Detecting Proliferating Cell 
Nuclear Antigen (PCNA) as a tissue marker indicates proliferative activity. 
 Aim: The aim of this study is to evaluate the proliferative and hypertrophic activities 
in the MCC and the GF during mandibular advancement in Sprague Dawley Rat’s 
Temporomandibular Joint (TMJ), evidenced by FGF8 and PCNA. 
 Methods and Materials: Fifty five female 24-day old Sprague-Dawley rats were 
randomly divided into four experimental and control groups, with mandibular advancement 
appliance on the experimentals’ lower jaw. The rats were euthanized on days 3, 14, 21 and 30 
of the study and their TMJ was prepared for immunohistochemical staining procedure to 
detect FGF8 and PCNA. 
 Results: FGF8 expression was significantly higher in the experimentals (p=0.002), 
while PCNA expression did not increase significantly in the experimental samples (p=0.327). 
The patterns of ascension and descension of FGF8 and PCNA expressions during the 
experiment period was similar in experimental and control samples. However, the number of 
stained cells for FGF8 and PCNA differed between the MCC and the GF. The results show 
an overall enhanced osteogenic transition occurring in both the MCC and the GF in 
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experimentals in comparison with controls. The level of cellular changes in the MCC is 
remarkably higher than in the GF. 
 Conclusion: In the MCC and the GF, hypertrophic differentiations increase 
significantly during mandibular advancement, while cellular proliferation does not increase 
significantly. It could be concluded that the endochondral ossification in the MCC and 
intramembranous ossification in the GF occurs during adaptive remodeling.  
 Keywords: Mandibular condylar cartilage, Glenoid fossa, FGF8, PCNA, Adaptive 
bone remodeling, Mandibular advancement.  
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1. Introduction 
 Several studies have discussed mandibular advancement as a functional therapy for 
skeletal class II malocclusion (1-3) and have shown that a fundamental factor in regulating 
cellular activities during tissue morphogenesis is mechanical stress (4, 5). The forward 
positioning of the mandible is followed by adaptive remodeling in the MCC and the GF (6-
10).  Many studies with rats and monkeys have also shown that new bone formation in the 
condyle and the GF occurs in response to mandibular advancement (10-12). 
 Growth modification of the lower jaw during mandibular forward positioning is a 
successful example for bone remodeling in response to a change in biophysical environment 
(3). Vertical opening and horizontal forward positioning as components of bite-jumping 
mode are both important elements in this biophysical change which induce the adaptive 
remodeling in the CC and GF (10, 11, 13). This remodeling occurs by expression of cells’ 
endogenous regulatory factors in the mandibular condyle through an endochondral 
ossification process in the MCC (2-7) and intramembranous ossification (IO) in the GF (8, 
10, 11, 14-16). 
 Osteogenesis through an endochondral ossification (EO) in the MCC is a pathway of 
phenotypic and morphologic change of mesenchymal cells from initiative immature cells in 
the condylar superficial layer, or articular zone, downward to mature bone-making cells in 
the erosive zone (8, 17-21). This process creates a zone-like pattern from the superficial layer 
downward: 1. Articular Zone, 2. Resting Zone, 3. Proliferative Zone, 4. Hypertrophic Zone, 
5. Erosive Zone (17, 22). It has been revealed that the mesenchymal cells are oriented in the 
CC, leading to cellular migration and condensation followed by differentiation into bone-
making cells (23).  
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The population size of the mesenchymal cells present in the sub-periosteal connective 
tissues of the MCC directly impacts the number of bone-making cells available to engage in 
the formation of new bone during craniofacial development.The undifferentiated 
mesenchymal cells in the Extra-Cellular Matrices (ECM) give rise to other cell types as the 
need arises and they are present in the ECM of developing bones in the skull, including the 
temporal bone (24, 25).  
 Mesenchymal cells are known to proliferate and multiply until they differentiate. 
Differentiation of mesenchymal cells into bone-making cells curtails the population size 
because the proliferative activity slows down as development continues (26). Another 
source of mesenchymal cells is the pericytes present in the peri-vascular sites surrounding 
migrating blood vessels. Pericytes are primitive cells that may act as precursors to other 
mesenchymal cells and the proliferative mesenchymal cells (27, 28), while the 
intramembranous ossification is the main part of the osteogenesis pattern in GF. Thus, 
mesenchymal cells directly differentiate into osteoblasts (14-16) known as osteoprogenitor 
cells (29, 30). Fibroblast-like cells proliferate to pre-osteoblasts or early osteoblasts to 
ultimately form bone (31, 32). 
The FGFs form a family of at least 23 growth regulatory proteins that share 35 – 50% 
amino acid sequence identity. Proliferation and differentiation in a wide range of cells of 
epithelial, mesodermal and euroectodermal origin are induced by this protein family (33-41) 
and they regulate mesenchyme and chondrocyte proliferation in the MCC adaptive 
remodeling (17). FGF signaling results in a decrease in chondrocyte proliferation and an 
acceleration of hypertrophic differentiation and morphologic changes in chondrocytes (9). 
The relative expression domains of members of the FGF and TGFβ signaling 
pathways facilitate functional studies on endochondral ossification, which will contribute to a 
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better understanding of the molecular regulation of bone development. FGF8 is expressed in 
highly proliferating, columnar chondrocytes, in early hypertrophic and hypertrophic 
chondrocytes (42).  
PCNA is a marker for cell proliferation (43, 44). PCNA is a highly conserved protein 
expressed at high levels in dividing cells. It is discovered as a stimulating factor for DNA 
polymerase (44, 45). PCNA detection in cells indicates proliferative activity as it functions as 
a DNA sliding clamp for DNA polymerase delta, and is also an important component in 
eukaryotic chromosomal DNA replication (43, 45). PCNA detection is an established method 
for studying the proliferation activity of cells in developmental processes (45-47). The PCNA 
is detected in the nucleus of dividing cells.  
The aim of this study is to evaluate the proliferative and hypertrophic activities in the 
MCC and the GF during mandibular advancement in Sprague Dawley Rats, as evidenced by 
the FGF8 and PCNA. FGF8 is an indicator for cellular chondrogenic and morphologic 
differentiation and hypertrophic activity, and PCNA is a tissue marker as an indicator for 
cellular proliferation; these factors are used to demonstrate the histochemical nature of bone 
adaptive response to mandibular protrusion. Thus, this study is designed to evaluate the 
histochemical changes resulting in TMJ remodeling and mandibular growth modification into 
a forward position. 
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2. Literature Review 
2.1. Introduction 
 Orthodontics is defined as a branch of dentistry concerned with facial growth, dental 
development, and prevention and correction of occlusal anomalies (48). Clinical orthodontics 
requires an understanding of both dental development and general concepts of physiological 
and physical growth ((49) p. 25)). It also involves the use and control of force acting on the 
teeth and associated structures such as sutures and TMJ ((50) p. 145)). 
 An orthodontic problem could be attributable to dental disorders, craniofacial skeletal 
anomalies or combinations of both. These problems based on the inter-arc dental and skeletal 
relationship are divided into different subgroups as Cl I, Cl II and Cl III malocclusions. 
Skeletal Cl II malocclusion is one of the most common orthodontic problems which may be 
caused by mandibular deficiency, excessive growth of the maxillary or a combination of 
these. When the mandible is small or retruded relative to the maxilla, it is called a mandibular 
deficiency which is the most consistent diagnostic finding in Cl II malocclusion ((50) p. 9, 
(51)).  
 Skeletal problems may be treated - based on several factors - by functional appliances, 
orthognatic surgeries or a combination of both ((50) p. 9, (51)). Growth modification by 
using headgear or functional appliances is a choice for Cl II treatment in growing patients  
((52) p. 329-34) (53)). The current research is a histochemical study on the MCC and the GF 
during mandibular advancement, as a functional treatment for skeletal Cl II problem.  
 Controversy continues regarding the precise nature of the skeletal changes during 
growth modification of the maxilla and the mandible, although little argument remains that 
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orthopaedic force may modify the growth of the maxilla and the mandible (54). Histological 
and biochemical research in this field, such as the current study, could provide basic 
information about the nature of the skeletal growth modification in response to orthopaedic 
forces. 
2.2. Functional Mandibular Advancement 
 Functional appliance is a term used for an orthodontic appliance which forces the 
mandible into an eccentric/non-eccentric relation position while it is fully seated in the 
mouth. Most commonly, functional appliances are used in cases of mandibular protrusion to 
correct the skeletal Cl II relationships. The occurrence of significant additional growth from 
this approach is not fully verified by different studies in this field, but it has clearly been used 
with successful results ((52) p. 220-21, (55)).  
 Norman Kingsley introduced the “bite-jumping” appliance in 1879, and the history of 
functional appliances traces back to that year (56). Since the late 19th century many types of 
bite-jumping functional appliances have been endorsed to treat growing patients. The basic 
principle for all bite-jumping functional appliances is to keep the mandible in a protrusive 
position in an attempt to induce condylar and then mandibular growth. There are different 
removable bite-jumping functional appliances with similar basic principals; activators, 
bionators, Clark twin block and Frankel functional regulator II (FR II) with various 
modifications. Fixed bite-jumping functional appliances were well represented by Herbst 
appliances, which originated around 1905, and Pancherz reintroduced them in the early 
1970s. A continuous mandibular protrusion is created by the telescope mechanism of the 
Herbst appliance (reviewed by Shen et al 2005 (57), (55)). 
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 A therapeutic approach which enhances the mandibular growth is required for skeletal 
Cl II treatment (17, 57, 58). A wide range of functional appliances are available to correct 
this type of skeletal and occlusal disharmony, all of which aim to stimulate mandibular 
growth by forward positioning or vertical bite-opening, or a combination of these two 
methods (3, 49, 50, 55, 59-62). Although many animal studies demonstrate skeletal 
mandibular changes in response to mandibular forward posturing (6-8, 63-65), the 
observations in human studies are more equivocal and controversial (57, 62, 66). 
 The effectiveness of functional treatment of mandibular growth deficiencies depends 
on several factors; the direction and magnitude of the force, the biological responsiveness of 
the MCC, the mandibular growth rate (pre-peak, peak, and post-peak growth rates with 
regard to the pubertal growth spurt) and treatment duration (17, 57, 62, 67-69). The effect of 
functional treatment with the Cl II activator and the Cl II activator high-pull headgear was 
recently studied on a 3D finite element model of the human mandible. The study 
demonstrated that the mandibular body is subjected to higher stress than the condylar region 
and the muscle attachment regions obtain the maximum stress values, such as the coronoid 
process (70).  
 The assessments show that forward positioning of the mandible by continuous bite-
jumping in young adult patients with Cl II malocclusion results in remodeling of the TMJ 
(17). In human studies the Herbst appliance is considered the highest coefficient of efficiency 
by 0.28 mm/month (average amount of actual extra elongation of the mandible in treated 
subjects), followed by the Twin-block by 0.23 mm/month (62). 
 Immediate alteration of the neuromuscular activity of the orofacial muscles to the 
functional position of the mandible is indicated by McNamara et al (1979). This immediate 
neuromuscular activity is particularly noticeable in the lateral pterygoid muscle. The 
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neuromuscular alterations closely follow the facial skeleton adaptive responses. The various 
adaptive responses depend on the maturational status of the animal. These adaptations 
continue until the structure of the skeletal and dentoalveolar components of the craniofacial 
complex are complete (65).  
 Several structural mechanisms could be involved in the effectiveness of functional 
appliances to obtain a Cl II correction; (1) retardation or redirection of the mesial and vertical 
maxillary growth, (2) retardation of the mesial and vertical maxillary dentoalveolar growth, 
(3) encouragement of mandibular growth, including condylar growth, in response to anterior 
displacement of the condyle, (4) growth of the mesial and vertical mandibular dentoalveol, 
(5) combined maxillary and mandibular orthopedics effect with maxillary incisor lingual 
tipping and mandibular incisor labial tipping, resulting in overjet correction, and (6) TMJ 
remodeling (reviewed by Bishara et al 1989 (55)). 
 The current study is performed to clarify the nature of the successful effect of 
mandibular advancement at a biological level by using rat experiments. 
2.3. TMJ Bone Remodeling and Growth Modification 
 Maxilla and mandible are the boney structural bases of the stomatognathic system. 
TMJ, periodontal ligament (PDL), alveolar process and maxillary sutures biomechanically 
are skeletal structures more reactive to physiologic and therapeutic biomechanical stimuli, in 
comparison with other parts of the jaws (Table  2-1).  The jaws respond to functional and 
therapeutic loading via the bone modeling and remodeling mechanisms.  
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Stomatognathic Adaptation 
 
Structural Bases 
 
Maxilla Mandible 
 
Most Reactive Parts 
 
TMJ Alveolar process Maxillary sutures PDL 
Table  2-1 Stomatognathic adaptation 
 Most of the responses to the orthodontics and dentofacial orthopedics are associated 
with the TMJ, alveolar bone, maxillary sutures and PDL (modified from Roberts et al 2004 
(71)).  
 
 The TMJ response to functional and orthopedic appliances has been studied through 
clinical procedures and animal experiments. It is necessary to understand the nature of the 
TMJ tissues and their relations during normal growth, maturation and orthodontic treatments, 
for an effective consideration of the potential association between tissue response in the TMJ 
and orthodontic treatment. Most of the investigations of the TMJ are in various experimental 
animals. However, in humans, very few postnatal investigations of the TMJ development are 
available ((50) p.191-96) (50, 72-75)). During the postnatal period, the TMJ becomes a 
secondary growth site. It has two articular surfaces that can adapt to environmental changes 
((summarized in Table  2-3) (72, 76)). 
 The MCC is a secondary, fibrous type cartilage and does not originate from a primary 
cartilage precursor. It is highly responsive to mechanical stimulation and grows 
appositionally from its peripheral. This anatomic position is altered by continuous 
repositioning of the mandible to its best possible functional advantage during craniofacial 
growth and TMJ adaptive remodeling. Mandibular posture maintenance is facilitated by both 
mechanisms of TMJ remodeling and continuous mandibular reposturing. The MCC has its 
own intrinsic growth but does not generate tissue-separating forces similar to epiphyseal 
plates ((52) p. 49-50, (77)). 
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  Remodeling of the GF and the compensatory growth of the MCC adjusts with the 
anatomic position of the MCC in the GF. In the GF, the subarticular proliferative zone can 
support both anabolic and catabolic bone modeling to change the shape and position of the 
temporal fossa in response to environmental changes (71). The GF formation is induced by a 
wide range of repetitive motion and pressure against the temporal bone with cortical bone 
apposition (78). 
 Studies on monkeys and rats have shown the capability of functional adaptation in the 
TMJ to mandibular forward displacement. In some studies amplification in osteoblasts and 
prechondroblast mitotic activity is observed as the initial influence of functional mandibular 
advancement with acceleration in differentiation of osteoprogenitor cells to prechondroblast. 
This is followed by observing an increase in transformation of prechondroblast into 
functional chondroblasts, and more chondroblastic hypertrophy with accelerated 
endochondral bone growth. An increased number of dividing cells resulting in an increased 
thickness of the prechondroblast proliferative zone is reported ((50) p. 191-96) (79)). 
However, in the current research the level of proliferation in the condyle is not significantly 
increased during mandibular advancement. 
 The growth rate in rats and monkeys is faster than in human beings, and it is easier to 
control interfering factors such as cooperation in rats and monkeys. Therefore, the effect of 
mandibular anterior displacement in animal studies shows more consistent results, while 
observations made in clinical studies show greater discrepancies. Although it is difficult to 
clearly prove whether the growth of the human mandible is altered by orthopedic and 
functional forces, research shows orthopedic change is a combination of mandible and GF 
change ((50) p. 194)). 
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 A balance of factors is at work with orthopedic appliances controlling the MCC-GF 
modification. At least six factors that interact and produce a positive change for each 
individual are identified in the growth relativity hypothesis: 1. Skeletal displacement, 2. 
Dental, 3. Neuromuscular, 4. Non-muscular viscoelastic tissues including synovial fluids, 5. 
Biodynamic intrinsic and extrinsic factors, and 6. Maturational age. These all contribute to 
adaptation in the TMJ complex (Figure  2-1) (80).  
 
Figure  2-1 Growth Relativity Hypothesis Elements 
 The diagram shows the biodynamic factors involved in reactions between MCC-GF 
complexes to orthopedic mandibular protrusion. Extrinsic factors involved in the metabolic 
action of both MCC and GF are mentioned in the main circle (Biodynamic Intrinsic and 
Extrinsic Factors: Nutritional, Hormonal, Autoimmune, Oxygen Tension, other). The inner 
circles indicate the different factors of the growth relativity hypothesis and their possible 
overlaps during mandibular protrusion and retention (Viscoelastic, Dental, Skeletal, 
Neuromuscular) (modified from Voudouris et al 2000 (80)). 
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 The growth relativity hypothesis is presented by Voudouris et al for the mechanism of 
MCC-GF growth modification with mandibular advancement. It involves: 1. Mandibular 
displacement, 2. Tissue extension forces applied to the MCC-GF through several different 
attachments known as viscoelastic forces, 3. Transduction of forces radiating beneath the 
fibrocartilage of both condyle and GF. The MCC and GF are contiguous structures, 
interconnected by retrodiscal tissues, and these three mechanisms result in MCC-GF growth 
enhancement, growth redirection and ultimately TMJ growth remodeling (80). The 
Functional matrix theory is the other hypothesis which describes the possible mechanism of 
bone remodeling in the MCC-GF complex in response to propulsive forces (81-85). 
Genetic Patterning 
 
Neural crest cell migration Nerve growth factors 
 
Cartilage Anlage1 Para-vascular condensation of mesenchyme 
 
Endochondral Bone Intramembranous Bone 
 
Vascular induction and invasion
 
Ossification Centres
 
Table  2-2 Osteogenesis Genetic Patterning 
 Genetic patterning in craniofacial ossification centres involves neural crest cell 
migration along the pathways of nerve distribution. Cartilaginous or intramembranous 
structure formation is the result of these biologic pathways (modified from Roberts et al 2004 
(71)). 
 
 The neurovascular distribution seems to control the patterning of ossification and 
subsequent response to mechanical loading of both endochondral and intramembranous bones 
(32).  
                                                 
1 Anlage, in embryology, is the primordium which is the initial clustering of embryonic cells. 
It serves as a foundation from which a body part or an organ develops.  
31 
 
 Generally, three physiologic possibilities are involved at any given site when a bone is 
adapting to changing loads: 1. Bone apposition, 2. Bone resorption, or 3. No change. 
Repetitive loading indicates the pattern of the three types of site-specific activity. The 
“Flexure law of bone modeling” refers to the phenomenon that “bone bending” results in 
patterns of surface compression and tension. These are potential sites of bone formation and 
resorption. Bone is generally capable of flexure up to about 2.5% without fracturing (86). The 
biological response to applied mechanical forces is the physiologic mechanism for skeletal 
adaptation to the environmental changes.  
Mature TMJ Adaptation 
 
Articular Surfaces: Dense Fibrous connective tissue 
 
Subarticular Proliferative Zone 
 
Secondary Adaptation Sites 
 
Glenoid Fossa Condylar Cartilage 
 
Bone Modeling Fibrocartilage Plate 
 
Change Position Length & Shape Change 
 
Table  2-3 TMJ Adaptation 
 
 Normal TMJ is remarkably able to heal and adapt over a lifetime. The mechanism of 
continuous osseous adaptation in TMJ is similar to the covering periosteum of other bones. 
The fibrous layer of the periosteum is a dense fibrous connective tissue covering healthy 
articular surfaces and the subarticular layer is a cellular proliferative zone. The mandibular 
condyle and the GF adaptation occur during normal growth and in response to physiologic 
and therapeutic forces (modified from Roberts et al 2004 (71)). 
 A five-step sequence could be used for comparing the endochondral and 
intramembranous ossification ((52) p. 44-45) (32)); 
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Endochondral bone formation Intramembranous bone formation 
1 Chondrocytes hypertrophy and cartilage 
matrix calcification within the cartilage 
primordium matrix 
The ectomesenchymal condensation 
centres differentiate to osteoblasts then 
produce osteoid (a fibrous bone matrix) 
2 Invasion of blood vessels from the 
perichondrium and bringing undifferentiated 
connective tissue cells 
Osteoblast become osteocytes and blood 
vessels become surrounded by bone; 
Cells and blood vessels are encased. 
3 Osteoblasts differentiate form the connective 
tissue osteoprogenitor cells and deposit 
osteoid on the remnants of the calcified 
cartilage matrix 
Osteoblasts in the surface periosteum 
adding bone to the surface of the bone 
(appositional bone growth) 
4 Mineralization of the fibrous bone matrix Bone matrix mineralization 
5 Mature bone is covered with a membrane Mature bone is covered with a membrane 
Table  2-4 Endochondral and Intramembranous Ossification 
2.3.1. Endochondral Ossification 
 Endochondral bone formation in the craniofacial skeleton only takes place in the 
bones of the cranial base and portions of the calvarium ((52) p. 44-45) (71)).  
Endochondral Ossification 
 
Hyaline Cartilage 
• Interstitial growth 
• Tissue separating force 
• Growth against a  
pressure gradient 
Fibrocartilage 
• Load bearing tissue 
• Subarticular layer 
• Eroded by osteoclast 
• Replaced by bone 
 
Growth Centres 
• Epiphyseal growth plate 
• Synchondrosis 
Growth Sites 
∗ Mandibular condyle 
∗ Palatal sutures 
 
Produces Primarily Trabecular Endochondral Bone  
 
Table  2-5 Endochondral Ossification 
 Growth plates and synchondrosis are examples for endochondral bone formation via 
hyaline cartilage. These are primary growth centres. The mandibular condyle and early 
postnatal growth of palatal sutures are examples for endochondral bone formation via 
fibrocartilage structure. Fibrocartilage is the precursor for secondary growth. Characteristic 
patterning of trabecular endochondral bone is caused by the vascular invasion process during 
endochondral ossification (modified from Roberts et al 2004 (71)). 
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 During the endochondral bone formation, chondrocytes initially proliferate and 
differentiate into hypertrophic chondrocytes. After that, many chondrocytes are dissolved and 
the remainders are mineralized and die. The mineralized matrix is removed by osteoclasts and 
the chondrocyte lacunae are eroded as the cartilage matrix calcifies. Osteoclast and 
mesenchymal precursors are derived by growth of vascular tissue into bone. The degraded 
matrix is replaced by cellular bone formed by osteoblasts. The osteoblasts act in organized 
units. Ultimately, bone tissue forms around the calcified cartilage, while capillaries with 
osteogenic cells invade the lacunae ((87) p.111-44) (88), (89)).  
 Previous studies indicate that hypertrophic chondrocytes can transdifferentiate or de-
differentiate and re-differentiate into bone cells, osteoblasts/osteocytes, during the 
endochondral bone formation. They have also indicated that hypertrophic chondrocytes 
persist during endochondral bone formation, and it is frequently reported that at least a few 
chondrocytes possibly survive and enter the primary spongiosa of the MCC. This indicates 
that occasional survival of hypertrophic chondrocytes might be a structural feature of the 
condyle. 
 Meanwhile, in ultra-structural studies with improved fixation methods, the formation 
of a mainly non-collagenous matrix (presumably proteoglycans) is shown around 
hypertrophic chondrocytes in the peri-cellular matrix. Further investigations have also 
reported the formation of thick collagen fibrils in the peri-cellular matrix of hypertrophic 
chondrocytes in an aged rat’s MCC and trachea, and in the MCC in rats with strontium 
rickets. Furthermore, Type I collagen have been detected in several immunohistochemical 
studies around the hypertrophic chondrocytes in the MCC. This indicates the importance of 
characterizing hypertrophic chondrocytes in various conditions by analysing the peri-cellular 
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matrix. Moreover, at least in part, long-term survived uneroded hypertrophic chondrocytes 
acquire osteocytic characteristics (reviewed in (90)). 
 The process of endochondral ossification is regulated at several levels by secreted 
signaling molecules of the FGF and transforming growth factor beta (TGFβ) families. 
Different dwarfism syndromes in humans, such as hypochondroplasia (91), achondroplasia 
(92), and thanatophoric dysplasia (93) are the results of  ectopic activation of FGF signaling. 
Evidence exists for several key molecular mechanisms that regulate these events. However, 
substantial gaps in understanding remain (89). 
 
Figure  2-2 Cartilage Differentiate to Bone 
 The diagram is a schematic view adjacent to a section from a human growth plate 
(1x2 mm). The tissue section is stained by Hematoxylin and Eosin (H&E); cartilage 
proteoglycans (blue) and bone collagen (red). A cell cannot lineage revert once it 
differentiates into cartilage or bone. Mesenchymal stem cells are required for continuing 
differentiation in bone. They differentiate into several cell types. Feedback between Indian 
hedgehog (Ihh) and PTHrP and differences in FGFRs and BMP expression are critical in the 
cartilage transition into bone. Normal differentiation requires many other factors, such as 
vitamin D. The developing bone is divided into apoptotic regions, in regard to the columnar 
formation of hypertrophic chondrocytes. These apoptotic regions become inter-trabecular 
spaces. The mineralized columns are the scaffold for osteoblast bone deposition, while the 
remaining mineralized cartilage is degraded (modified from Blair et al 2002 (89)). 
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 Complex interactions of local and systemic factors control the molecular mechanisms 
for developmental regulation of the growth plate. Bone morphogenetic proteins (BMPs) (94), 
wnts  (95), FGFs (96), hedgehog  proteins (97), parathyroid hormone-related protein (PTHrP) 
(98), insulin-like growth factors (IGF) (22), and VEGF (88) are some of the local factors. 
Some systemic factors are growth hormone, thyroid hormone, estrogen, androgen, vitamin D, 
and glucocorticoids. The systemic factors are involved in controlling the growth of long 
bones (reviewed by Kronenberg et al 2003 (99)).  
 Cancellous bone is the initial osseous structure resulting from endochondral bone 
formation. The cartilage cells die and the intercellular substance mineralizes.  On the other 
hand, osteoclasts erode the mineralized fibrocartilage in the mandibular condyle and the 
fibrocartilage is replaced by lamellar bone apposition. Fibrocartilage is formed by the 
subarticular proliferative zone in the condyle and is a load-bearing tissue. In the metaphysis 
of both the mandibular condyle and long bones, lamellar trabeculae that are aligned along the 
line of stress are the final remodeled structure in this process (71). This progress reflects 
Wolff’s law2 in the MCC and long bone (100, 101). 
2.3.2. Intramembranous Ossification 
 Intramembranous ossification initiates with intramembranous condensations of 
mesenchyme, adjacent to blood vessels. This process initiates the formation of the flat bones; 
facial bones, cranium, sternum and scapula. The intramembranous ossification is the origin 
                                                 
2 Wolff's law, the law of bone remodeling, states that bone in a healthy person or animal will 
adapt to applied loads. The bone will remodel and become stronger in response to the 
increased load to resist that sort of loading. Furthermore, the external cortical portion will 
become thicker in response to the loads. Conversely, if the load decreases, the bone will 
become weaker due to turnover (Wolff J.  "The Law of Bone Remodeling" Berlin Heidelberg 
New York: Springer, 1986 (translation of the German 1892 edition) (cited from Wikipedia 
website, 15DEC2008)).  
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for sub-periosteal bone formation which represents a high degree of vascularity and lack of a 
cartilage precursor. The areas where growth factors are secreted lateral to neurovascular 
bundles seem to be the initial centre of ossification. The apposition rate will finally indicate 
the bone type which may be of the woven or lamellar type. Woven bone has a poorly 
organized matrix and is formed rapidly (up to 100 μm/ day) and Lamellar bone has a highly 
organized matrix and is formed slowly (less than 1 μm/day) (71). 
 Intramembranous bone formation is dependent on patent blood vessels along the bone 
surface. Therefore it cannot grow against a pressure gradient. This osteogenic mechanism 
occurs in some secondary growth sites such as the PDL, sutures and the TMJ (Table  2-6). 
Intramembranous bone formation at secondary growth sites is cortical bone which is formed 
of circumferential lamellae or primary osteons. It is in contrast to production of initial 
trabecular bone formation at endochondral growth centres (71). 
Intramembranous Ossification 
 
Woven Bone Lamellar Bone 
 
Primary Osteons Secondary Osteons 
 
Secondary Growth Sites 
 
PDL Sutures, Flat bones TMJ, Glenoid Fossa 
 
Produces Primarily Cortical Bone 
Table  2-6 Intramembranous Ossification 
 Intramembranous ossification produces a woven or lamellar bone, depending on the 
rate of apposition. All intramembranous bone formation is associated with secondary growth 
sites, such as the PDL, sutures of flat bones and some parts of the TMJ. Primarily cortical 
bone is the final production of the intramembranous ossification (modified from Roberts et al 
2004 (71)). 
 
 From a molecular point of view, it is demonstrated that for the elongation of Meckel's 
cartilage FGF Receptor 3 (FGFR3), signaling is required and during intramembranous 
ossification of mandibular bones, FGFR2 and FGFR3 are involved (30). 
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2.4. Mandibular Condylar Cartilage (MCC) 
 The MCC is an active growth site for the mandible (102), and it has been studied as 
the primary focus of functional orthopedic therapy for mandibular disorders (58). Animal 
experimentations, contrary to human experimentations, are performed for more than just 
linear measurement of condylar growth and provide an insight into the MCC. Condylar 
growth could be monitored by histological observation, which has been conducted to identify 
cellular response during chondrogenesis of the MCC (9). Examination of the expression of 
growth factors in the MCC in response to mandibular repositioning as a biochemical 
approach makes it possible to reveal intrinsic aspects of condylar growth at molecular or 
genetic level with animal models (7). 
 The postnatal growth of the condyle proceeds through the biological process of 
endochondral ossification. This process is regulated and orchestrated by different growth 
factors which are mainly synthesized by chondrocytes (103). Several growth factors are 
studied in this field, such as transcription factor Sox9 (a critical transcription factor for 
differentiation of the mesenchymal cells into chondrocytes) (104, 105) parathyroid hormone-
related protein (PTHrP) (106) and matrix metalloproteinase 13 (MMP- 13) (107), etc. These 
growth factors control condylar bone formation by facilitating and mediating the 
biomolecular pathway of endochondral ossification. The correlation between synthesis of 
some growth factors and progression of condylar bone formation have been discovered by 
Rabie et al with a series of biochemical examinations on animal experimentations (108). The 
biochemical examination of growth markers, such as type X collagen, is also suggested as a 
new approach to accurately represent the temporal pattern of condylar growth (109). 
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Even though the histomorphologic picture of the condyle varies in different stages of life, 
the following layers can usually be seen: 
1. Surface Articular Zone, fibrous connective tissue. 
2. Resting Zone. 
3. Transitional or Proliferative Zone, containing proliferative cells and a transitional 
stage between undifferentiated cells and cartilage cells. 
4. Hypertrophic zone, chondrocytes but not in a columnar order like epiphyseal bone. 
5. Erosive Zone. 
6. Bone formative zone, endochondral bone ossification ((50) p. 191-96) (17, 109)).
  
Figure  2-3 Histomorphologic picture of the Condyle 
 The image is a sagittal section of a 44 day-old Sprague Dawley rat’s condyle after 21 
days of mandibular advancement, immunohistochemicaly stained for FGF8. Six different 
cellular layers can typically be seen, which are named in the image as the histomorphologic 
picture of the condyle.  
 
 
1. Articular Zone  
 ………………..... 
 
2. Resting Zone 
 …………………. 
 
3. Proliferative  Zone 
  
 …………………. 
 
 
 
4. Hypertrophic  Zone 
 
 
 …………………. 
 
5. Erosive Zone 
 …………………. 
 
6. Bone  
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 The MCC has several differences from growth plate cartilage and the limb bud. For 
example, in development it shows delayed appearance relative to the limb bud cartilage and 
originates from the periosteum (98, 110, 111). There are also differences in its mode of 
proliferation and differentiation (112, 113), cell alignment, invading capillary pattern, and 
extracellular matrix composition (110, 114, 115). The MCC’s response to hormonal factors 
and mechanical loading is also different from growth plate cartilage and the limb bud’s 
response. The MCC is covered by a thin layer of undifferentiated cells directly overlying the 
cartilage of the condyle (articular layer). This is in contrast to epiphyseal growth of long 
bones which takes place through cleavage of previously differentiated mature cartilage cells 
(116). 
 The MCC is unlike most other cartilages of the body. Embryologically, it is not 
derived from the primary cartilaginous skeleton and is secondary in origin; like the articular 
cartilage of the clavicle, the cartilages of the coronoid process and the mental region of the 
mandible. It is biochemically distinct from the other growth cartilages of the craniofacial 
region and the appendiclular skeleton. Morphologically, the condyle’s different cellular 
layers appear to be continuous with the two major layers; the periosteum along the neck of 
the condyle with the articular layer corresponding to the outer fibrous periosteum, and the 
prechondroblastic-chondroblastic layer corresponding with the inner osteogenic layer of the 
periosteum.  
 Therefore, the cells of the prechondroblastic zone and the pre-osteoblasts of the rest of 
the periosteum of the mandible are homologous. Thus, it is expected that alterations in 
mandibular function result in an altered biomechanical or biophysical environment in the 
TMJ region and ultimately lead to an adaptive response in the cells of the MCC (discussed by 
McNamara et al 1979 (65)). 
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During natural growth, the migration of mesenchymal cells from the covering 
membrane towards the center of the condyle results from mitosis of undifferentiated cells. 
Then the mesenchymal cells differentiate to immature cartilage cells. Mitosis of 
undifferentiated mesenchymal cells is the source of new members of the MCC family. 
Subsequently, the immature chondrocytes progressively mature into the hypertrophic 
phenotype. During chondrocytes’ maturation, the calcification of the degraded cartilage, a 
preliminary stage of endochondral ossification, is facilitated by type X collagen. The extra- 
cellular matrix plays an important role in the differentiation of mesenchymal cells to 
chondrogenic cells. The cells within the articular layer are undifferentiated mesenchymal 
cells. They become pre-chondroblasts and later mature to chondrocytes (8).   
 Proliferative activity maintains in many of the condylar chondrocytes during 
hypertrophic differentiation in the late embryonic stage (98). Proliferating chondrocytes in 
CC could originate from the fibrous tissue layer covering the condyle. The fibroblasts and 
mesenchymal cells within the articular layer are found to be oriented in the direction of 
mandibular advancement. However, in mandibular natural posture the cells in this layer are 
packed parallel to the articular surface, showing no signs of strain. Functional appliances 
result in the stretch of the posterior fibres of the disc, and might also increase cellular density 
due to transverse compression; followed by an increase in cell-cell interaction (8).  
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(A) 
 Figure  2-4 MCC-GF Growth Modification 
 The diagram shows an overall clinical concept MCC-GF growth modification in 
response to mandibular advancement. Orthopedic advancement enhances the jaw’s growth 
(Treatment Modification arrow). However, relapses are reported in long term evaluations 
(Retention Long term arrow).  
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(B) 
Figure 2-4 MCC-GF Growth Modification 
 The Condyle, numbered from top to buttom: 1. Fibrocartilage, 2. Prechondroblasts, 3. 
Chondrocytes, 4. Erosive zone, 5. Endochondral ossification. The Epiphysis, numbered from 
top to bottom: 1. Reserve cartilage, 2. Proliferative zone, 3. Matrix calcification, 4. Erosive 
zone, 5. Endochondral ossification. The condyle of the mandible and the epiphysis of long 
bones have significant differences. The condyle has greater potential for modification. The 
epiphysis does not have a fibrocartilage covering layer, but the condyle does. In comparison 
with epiphyseal chondrocytes, condylar prechondroblasts are not surrounded by an 
intercellular matrix. Therefore they are not isolated from local factors. The chondrocytes are 
in a columnar arrangement in the epiphyseal, but they are further oriented in a 
multidirectional fashion. This arrangement is more suitable for changes in growth direction in 
comparison with epiphysis (modified form Voudouris et al 2000 (80)). 
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Histochemical Changes in Condylar Cartilage during Mandibular 
Advancement 
 Forward mandibular positioning produces biomechanical forces which solicit cellular 
and molecular changes in the mandibular condyles (6, 7, 23, 117). However, several studies 
have reported a positive response of the condyle to mandibular advancement. Controversial 
issues remain in this regard and the triggering mechanisms are not completely understood (7, 
8, 65, 103, 118). Although the effect of bite-jumping appliances on the growth of the 
mandibular condyle remains controversial in the orthodontic literature (57), with a better 
understanding of condylar adaptive responses to condylar repositioning, improved treatment 
approaches to functional appliances could be developed, based on scientific principles. 
 Some researchers believe that the actual growth of the mandible is the positive 
response to mandibular advancement (119, 120) while later studies indicate that functional 
treatments help the mandible to reach its final size by growth acceleration without producing 
a larger size overall (6, 121). The reason for this controversy is an apparent lack of tissue 
markers to distinguish between the two processes of actual growth and growth acceleration 
(6). It is reported by Rabie et al 2003, that forward mandibular positioning accelerates and 
enhances the expression of Sox 9 and type II collagen leading to acceleration and 
enhancement of the chondrocyte differentiation and cartilage matrix formation in the 
mandibular condyle. However, for most of the growth period, this enhancement of growth did 
not result in a subsequent pattern of subnormal growth. Therefore, functional appliance 
therapy could induce true enhancement of condylar growth (6). 
 A close correlation exists between mandibular condylar repositioning and the 
modification of condylar growth, which results in thickening of the posterior part of the 
MCC. An increase in the total amount of DNA without a significant increase in proliferation 
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of the cells in the mandibular condyle is reported in response to mandibular advancement 
(122). Condylar adaptation to forward positioning has invariably been reported by a series of 
experimentations in rats, indicated by increased synthesis of growth regulatory factors such 
as Indian hedgehog (Ihh) (123) and parathyroid hormone-related peptide (PTHrP) (106). A 
considerable increase in endochondral ossification of the condyles is reported by Shen et al, 
in response to mandibular forward positioning by detecting the expression of type X collagen 
in rat samples (8). Significant increase in the rate and extent of condylar growth in response 
to forward condylar advancement is also reported in young Rhesus monkeys (63, 64, 124).  
 The maturation of the chondrogenic cells is triggered by mandibular condylar 
advancement, followed by an increase in endochondral ossification in the condyle. An 
increase in the proliferating cells in the mandibular condyles in addition to enhancing their 
differentiation could result in increased bone formation. This indicates that the MCC will 
adapt and remodel in response to the biophysical environment of the TMJ, regardless of the 
presence or absence of growth potential (8). There is a close correlation between the increase 
in the cartilage matrix and the increase in the amount of bone formed in response to 
mandibular advancement (6). It is also shown that longitudinal bone growth primarily 
depends on chondrogenesis (125). 
 The physical stretching and reorientation of mesenchymal cells in the articular layer 
might trigger the enhanced differentiation and maturation of chondrocytes. A source of 
mesenchymal cells could be the blood supply in the posterior connective tissue of the 
condyle. The blood vessels supplying the condyle are mainly localized in this particular area. 
Mandibular protrusion causes the posterior fibres of the disc to stretch, subsequently leading 
to an increased emergence of new blood vessels, or neovascularization, in this area. More 
mesenchymal cells are brought to the area by the increased neovascularization and induce an 
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enhanced differentiation and maturation of chondrocytes (126). Subsequently an increased 
bone formation replaces the terminally hypertrophic cartilage, followed by an increased 
synthesis of type X collagen and increased bone formation (8). 
 
(A) 
Figure  2-5 Advanced Condylar Cartilage and Glenoid Fossa 
 The diagram shows the advanced MCC and GF through their respective soft tissue 
attachments that change their growth directions.  
 
Changes in the biophysical environment of the TMJ by forward mandibular 
positioning leads to the release of regulatory factors and enhancing condylar growth (6, 7). 
They also lead to a change in the condyle’s morphology and angular relocation of the 
condylar head and new bone apposition, mainly located in the posterior part of the condyle 
(7, 65).  An experiment on monkeys shows that the prechondroblastic-chondroblastic 
cartilage are significantly hypertrophic in the posterior condylar region, with a thickness three 
times that seen in normal monkeys (65). It is also demonstrated in adult rats, that by 30-day 
continuous mandibular advancement, adaptive morphological changes could be achieved in 
the MCC (127). The remodeling of the condyle ultimately results in a mandibular length 
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increase. The opinion that the length of the mandible is not entirely predetermined by genetic 
factors is consistent with this report (79, 128). 
 
(B) 
Figure 2-5 Advanced Condylar Cartilage and Glenoid Fossa 
 The diagram is a schematic illustration about the light bulb analogy of condylar 
growth and retention. The fact that a dimmer switch lights up the light bulb is schematically 
compared with continued advancement which lights up the growing condyle. The other 
elements are compared with different elements of the MCC-GF complex; muscles, retrodiscal 
tissues, etc. This is to describe the MCC-GF modification mechanisms and growth relativity 
hypothesis (modified from Voudouris et al 2000 (80)). 
 
  It should be considered that the changes in the MCC in response to mandibular 
advancement are highly related to the duration of functional therapy (65, 109), direction, 
amount and types of the force (57, 66, 129).  
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2.5. Glenoid Fossa (GF) 
 The temporal component of the TMJ is the S-shape curve of the temporal bone, the 
mandibular fossa and articular eminence, facing the articular zone of the condyle. It is lined 
with connective tissue and remodeling is observed in humans from early childhood in this 
articular fossa. The GF normally grows in a posterior and inferior direction. ((50) p. 
194)(76)).  
 Growth and development in the GF is regulated by endogenous factors and molecular 
markers expressed by cells as well as in the condyle (12). A significant appositional or 
periosteal bone formation is seen in the fossa in response to propulsive mechanical stimuli of 
the condyle. The growth and remodeling process is mediated by several intrinsic and extrinsic 
biofeedback factors (12, 79, 130). 
Histochemical Changes in Glenoid Fossa during Mandibular 
Advancement  
 The mandibular GF is rarely studied as a primary objective when investigating the 
effect of functional appliances (12, 130-133). Forward mandibular positioning significantly 
increases bone formation in the GF. Continuous bite-jumping in young rats results in 
enhanced mandibular growth and remodeling of the GF (12).  
 The remodeling of the GF due to mandibular advancement is also investigated in 
experiments on monkeys (64, 128, 134). MRI’s for patients who received Herbst appliance 
therapy also shows that a combination of condylar growth and remodeling of the GF occurs 
during the TMJ’s adaptive response to mandibular advancement in humans (3, 135). Changes 
in the GF are demonstrated in some human studies after treatment by an activator (2) or 
Herbst appliance (10, 136). It is suggested that the GF relocation contributed to the correction 
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of skeletal Cl II Division 1 malocclusion in combinations of mesial movement of mandibular 
teeth (137). Its adaptive capacity has also been demonstrated in human studies of condylar 
fractures (138).  The GF changes are also observed in several animal studies by radiographic 
and/or morphologic and histological investigations (12, 80, 134, 139, 140). However, there 
are few reports documenting how much new bone formation takes place in the GF in 
response to mandibular advancement, and by which mechanism this newly formed bone is 
induced in response to such advancement. 
 New bone formation is directly correlated with the amount of blood vessel invasion in 
the GF during natural growth and in response to mandibular advancement.  A significant 
increase in vascular endothelial growth factor (VEGF) expression and new bone formation 
occurs mainly in the posterior region of the GF (69, 133). Neovascularization is enhanced by 
VEGF which increases the number of mesenchymal cells in the perivascular connective 
tissue and stimulates the vascular endothelial cells to secrete growth factors and cytokines 
(130, 141).  
 The actual mechanism of bone formation in the GF is not completely understood and 
the regulatory factors governing its growth have not been fully identified. However, some 
researchers have proposed that the formation of this kind of intermediate type of tissue is 
transdifferentiation of chondroid cells into either chondrocytes or osteoblasts, depending on 
the biochemical environment (12); however, this has yet to be precisely evaluated since bone 
formation in the GF is reportedly intramembranous (74). 
 The articular fibrous tissue from the osteoid tissue is separated by the undifferentiated 
reserve cells which are densely packed together toward the articular side of the GF. 
Osteoblasts and lacunae with osteocytes are observed in the cancellous bone layer, and the 
abundant dense collagenous osteoid substance surrounds the lacunae. The arrangement of the 
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bundle of collagen fibers is parallel to the articular surface of the GF and marrow spaces are 
evident in the bone. Fewer lacunae are present in the deeper down cancellous bone (12).  
 
       Figure  2-6 TMJ Growth Modification 
        Growth modification in the MCC and GF is influenced by three factors: A. 
Displacement, B. Viscoelastic tissue pulls (arrows), C. Transduction with fibrocartilage. 
Viscoelastic tissue includes three parts: superior and inferior bands of the retro-discal fibers 
(B1); fibrous capsule (B2, fine white lines); and synovial fluid perfusion in a posterior 
direction (B3). The articular disc’s (blue region) posterior, anterior, lateral and medial 
(collateral) attachments translate the forces to the condyle in a posterior-superior direction 
and to the GF in an inferior-anterior direction (modified from Voudouris and Kuftinec 2000 
(80)). 
 Furthermore, in Rabie et al 2001 experiment on rat samples, no obvious cellular 
changes were observed in the GF. However, some cellular changes were observed in the 
posterior aspect of the GF. In the fibrous layer, the fibroblasts were round at the beginning of 
the experiment but stretched, flattened and increasingly oriented in the direction of the pull 
by disc fibres during mandibular protrusion. 
 The mesenchymal cells beneath the fibrous layer were arranged in line with the 
articular surface on 38 day-old rats after 3 days of mandibular advancement. However, the 
axis of the mesenchymal cells and other cells in the extracellular matrix (ECM) are oriented 
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in the direction of the pull and became increasingly aligned with the presumed direction of 
the pull (12). Mechanical strains can bring such “strain alignment”, which may influence 
migration or condensation of the mesenchymal cells. When mandibular advancement results 
in the stretch of the sub-periosteal ECM, its matrix density will increase because of the 
transverse compression caused by the Poisson effect 3(142, 143). This may attract more cells 
from the adjacent ECM as a source of mesenchymal cells (144-147). The perivascular 
connective tissue that surrounds the new blood vessels could be known as the other source of 
mesenchymal cells. These blood vessels are recruited in response to the stretching effect. The 
growth potential of the condyle and the GF is influenced by the number of replicating 
mesenchymal cells (148). In the cancellous bone layer, at the beginning of mandibular 
protrusion, the osteoblasts and osteocytes were randomly packed (12). 
 It has been hypothesized that bone formation in the condyle and the GF due to 
mandibular advancement is induced by viscoelastic force, generated in the synovial fluid of 
the joint capsule through the connective tissue attachments of the articular disc complex and 
retrodiscal tissue. This bone formation takes place especially in the posterior region (80). The 
biomechanical mandibular forward positioning changes the ECM and the undifferentiated 
mesenchymal cells in the sub-periosteal connective tissue in the GF (12). Furthermore, the 
changes in cell-cell and/or cell-ECM interactions activate the mechanical signal transduction 
cascade, through a transduction molecule (149).       
 MRI assessment in clinical studies with the use of the Herbst appliance shows that the 
GF remodeling and temporal adaptive responses occur later than the condylar adaptive 
                                                 
3 “When a tensile stress is applied to a material, the material elongates in the direction of the 
applied stress, and contracts perpendicular to the direction of the applied stress. This 
relationship, called the Poisson effect, is a natural response to applied stress that occurs with 
all materials, but is particularly apparent with ductile materials”. 
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response. The difference between the periosteal ossification of the temporal bone and the 
endochondral ossification of the condyle could be the reason of this nonparallel adaptive 
response. However, it should be considered that periosteal ossification does not result in a 
marked change in MRI signal intensity, because it is not associated with a large increase in 
water content of the tissue. Therefore, the mentioned delayed ossification in the GF and new 
bone apposition along the post-glenoid spine might be due to its later visualization in the 
MRI, at the time when the newly formed bone has consolidated (150-152). 
 Bone formation and the number of replicating cells in the posterior region of the GF is 
significantly higher than in the anterior and middle regions, which could be due to the 
primary attachment of the posterior fibrous tissue of the articular disc to this particular zone 
(10, 16, 148). 
2.6. Fibroblast Growth Factor (FGF) 
2.6.1. Fibroblast Growth Factors family: 
 FGFs are small polypeptide growth factors, and they share certain structural 
characteristics in common. Many FGFs are secreted into the extracellular environment and 
they contain signal peptides for secretion. There they can bind to the Heparan-like 
Glycosaminoglycans (HLGAGs) of the Extracellular Matrix (ECM). From this reservoir, they 
can act in different ways. They can act directly on target cells or be released through 
digestion of the ECM or the activity of a secreted FGF binding protein as a carrier protein. 
 In the context of HLGAGs, FGFs bind specific receptor tyrosine kinases. These 
bindings induce receptor dimerization and activation. The activation of various signal 
transduction cascades is the ultimate result in this process. Some FGFs are effective 
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angiogenic factors and most of the FGFs play important roles in embryonic development and 
wound healing. Basic cellular activities are governed by cell signaling as a part of a complex 
system of communication and this signaling progress also coordinates cell actions (153). FGF 
signaling seems to play a role in tumor growth and angiogenesis, and autocrine FGF 
signaling may be particularly important in the development of steroid hormone-dependent 
cancers to a hormone-independent state (Abstracted by Powers et. al. 2000 (40)). 
 Twenty distinct FGFs have been discovered and numbered from 1 to 20. FGFs in cells 
of mesodermal and neuroectodermal origin induce mitogenic, chemotactic and angiogenic 
activities on diverse target cells (33). FGFs’ family members are present in the extracellular 
matrix, most noticeably in FGF2, and their activity is through high affinity extracellular 
receptors; therefore, most FGFs act extracellularly (154). However, they are not only stored 
in the extracellular matrix itself, but also in endothelial cells (155) and fibroblasts (156). The 
Crystal Structure of FGF 8 isotope b (FGF8b) in complex with FGF Receptor (FGFR) 2c is 
shown in Figure  2-7. 
 FGFs, upon release to the ECM, quickly become associated with the HLGAGs. FGF 
protection from proteolysis and the creation of a local reservoir of growth factors may be 
afforded by this association. The protection of the FGFs from degradation and the creation of 
a local reservoir of growth factors are the two physiologically relevant goals of the FGFs. 
These goals may be served by the binding of the FGFs to heparin or HLGAGs. The role of 
FGFs in development is a clear example of the FGFs goal as a local reservoir of growth 
factors. 
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Figure  2-7 The FGF8b-FGFR2c complex and FGF8b’s overall feature 
 The Crystal Structure of the FGF8 isotope b (FGF8b) in complex with FGF Receptor 
(FGFR) 2c; FGF8b is one of the four human FGF8 splice isoforms, which is expressed in the 
mid-hindbrain region during development. 
(A) The figure represents the molecular surface of the FGF8b–FGFR2c structure. FGF8b is 
represented as a ribbon diagram and is colored orange. Alternative splicing modulates the 
biological activity of FGF8, therefore, phenylalanine 32 (F32, shown as sticks) is a key 
player in the FGF8’s molecular mechanism. D2 and D3 are receptors with a gray color 
linker. The constant N-terminal and the spliced C-terminal half of the D3 receptor are 
colored cyan and purple. The only three residues from the spliced N-terminal region of 
FGF8b are colored blue. 
(B) The diagram shows the contact between the N-terminal helix and beta4–beta5 loop of 
FGF8b with the D3 hydrophobic groove of FGFR2c, which dictate FGF8–FGFR-binding 
specificity. Interactions in stereo and coloring are the same as in A. F32 is the only 
residue from the alternatively spliced region of FGF8b that interacts with FGFR. 
(C) The spatial positioning of the FGF8b N terminus relative to the beta-trefoil core. The 
view of FGF8b is the same as in D. The surface of the FGF8b beta-trefoil core is shown 
as gray mesh. The beta1 strands and N termini of FGF8 is colored orange. The green and 
red ribbons are FGF1and FGF10. The blue is the ordered residue from the alternatively 
spliced region of FGF8b. The N termini of FGF8, FGF1, and FGF10 are labeled NT. 
(D) Ribbon representation of FGF8b from the FGF8b–FGFR2c structure. The beta-strands of 
FGF8b are marked based on the conventional strand nomenclature for FGF1 and FGF2. 
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(NT) N terminus of FGF8b; (CT) C terminus of FGF8b; (gN) N-terminal helix of FGF8b. 
The diagram, shown as ribbon, indicates intramolecular interactions that stabilize the 
unique conformation of the FGF8b N terminus and tether the N-terminal helix to the core. 
Dashed black lines show hydrogen bonds. Dashed green lines show the disulfide bridge 
between cysteines 109 (in beta6) and 127 (in beta8), which stabilize the conformation of 
the beta7–beta8 loop. This loop is one residue longer in FGF8 subfamily members with 
regards to other FGFs (modified from reference (157)). 
 
 FGFs play their mitogenic and angiogenic roles in target cells by signaling through 
cell-surface, tyrosine kinase receptors. Different cell responses to FGFs indicate that the 
different cells express altered forms of the FGF receptor. FGF is produced by cells, enters the 
ECM and eventually binds to cell surface receptors on target cells and activates them. 
Afterward, protein phosphorylation mediates a signal transduction cascade which is triggered 
by receptor binding. Small changes in gene expression are the ultimate result of this process. 
However, the biologic interaction between FGF secretion and receptor activation is not yet 
precisely clear. 
 Still, two mutually compatible mechanisms are reported on how the FGF may activate 
the FGFR from its association with the ECM. First, the FGF bound to the ECM may be 
available to cell surface receptors and may not actually be sequestered. The signaling 
pathway can be activated when a cell comes in contact with this FGF-primed ECM. This 
allows a strict spatial regulation of FGF signaling. The FGF may signal from the ECM to 
promote chemotaxis and cell migration during development with this mechanism. Second, 
proteolysis can rapidly mobilize this store of FGFs. This could be the activity of heparinases, 
or the activity of a secreted binding protein, the FGF binding protein (FGF-BP). This may 
explain FGF signaling during wound repair and tumor angiogenesis. Numerous proteolytic 
enzymes and heparinases are activated during these processes. 
 FGF receptors are similar to other receptor tyrosine kinases. Extracellular signals to 
various cytoplasmic signal transduction pathways through tyrosine phosphorylation are 
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transmitted by FGF receptors. Ligand binding and dimerization make the receptors capable of 
phosphorylating specific tyrosine residues on their own and each other’s cytoplasmic tails. 
Therefore, receptor dimerization is the key step from the extracellular to the intracellular 
signaling pathways. In craniofacial skeletogenesis, mutations of FGF receptors relate to 
syndromatic and non-syndromatic craniosynostosis (158). During long bone development, 
FGF receptors are expressed in different zones of the epiphyseal growth plates; FGFR3 in the 
proliferating chondrocytes; FGFR1 in the hypertrophic chondrocytes; FGFR1 and FGFR2 in 
the perichondrium (159, 160); FGFR2 is also expressed in early mesenchymal condensates 
and in the periosteal collar around the cartilage models (161). 
 Chondrocyte differentiation is critically controlled by FGF Receptors (FGFR3) 
signaling. For example, missense mutations in the FGFR3 gene cause three inherited human 
syndromes, hypochondroplasia, achondroplasia, and thanatophoric dysplasia (91-93, 162). 
The FGF signaling pathway in evolution is highly conserved and plays important and 
necessary roles in development. It is involved in almost all structural development in the 
craniofacial region, from early patterning to growth regulation. It is present in both the 
epithelia and mesenchyme and mediates the epithelial–mesenchymal interaction in advancing 
development. The FGF signal pathway plays crucial roles in suture and synchondrosis 
regulation during craniofacial skeletogenesis (158). 
 Some other functions are reported for FGF signaling: regulating chondrocyte 
proliferation and differentiation, acting upstream of Indian Hedgehog (IHH) in regulating the 
onset of chondrocytes’ hypertrophic differentiation (e.g. in FGF2 treatment) and accelerating 
the hypertrophic differentiation, acting as an antagonist of Bone Morphogenic Protein (BMP) 
signaling during cartilage development. Chondrocyte proliferation and hypertrophic 
differentiation is integrated by interaction of FGF, Ihh / PTHrP (Parathyroid Hormone-like 
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Peptide), and BMP signaling. Crystal Structure of FGF8 isotope b (FGF8b) in complex with 
FGF Receptor (FGFR) 2c is shown in Figure  2-7. 
 FGFs are involved in different biologic functions; angiogenesis and wound healing, 
inflammation (FGF1), repair (FGF2), regeneration (FGF7-FGFR2 (IIIb)), limb development 
(FGF5, 8 and 10). The most fully characterized role for FGFs is induction of limb buds 
(FGF3 and 4) and proliferation of developing limbs (FGF2 and 4) and cancer. FGFs have 
been reported to be relevant in organogenesis, especially in the nervous system, the lung and 
limbs (reviewed by Powers et al. 2000 (40)). 
2.6.2. Fibroblast Growth Factor8 (FGF8): 
 FGF8 was initially identified as an Androgen Induced Growth Factor (AIGF) found in 
the conditioned medium of the androgen-dependent mouse mammary carcinoma cell line SC-
3 (35). FGF8 has 7 isoforms, all with signal sequences. The amino-termini of these isoforms 
are different, but the signal sequence is not altered. FGF8 signalling is through FGF receptors 
1, 2-IIIc, 3-IIIc and 4 (FGFR1; FGFR2, IIIc; FGFR3, IIIc; FGFR4). In response to treatment 
with androgens in both the human breast cancer cell line MDA-MB-231 and the SC-3 cell 
lines, FGF8 was found to be expressed and secreted (163). Androgen induced growth of SC-3 
cells is blocked by a blockade of FGF8 activity by antisense oligo-nucleotides (164). This 
suggests that FGF8 plays a key role in mediating the effect of androgens on this cell line. It is 
reported that FGF8 is expressed by a great proportion of malignant breast and prostate 
tumors, and may be involved in the formation of osteosclerotic bone metastases (165). 
 FGF8 and its functions in some organs of chicks, fish, mice, rabbits, rats and humans 
in different life stages are widely studied (166-188). For example, some recent studies 
concern its role in inducing in vitro odontoblast-like cell differentiation of cranial neural crest 
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cells (169); its instructive role in limb proximal-distal patterning (189) and regulating 
mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis 
(96); its role in early human kidney development (172); its role in human prostate cancer 
(170, 171); its role in controlling regional identity in the developing thalamus (177) and the 
effect of decreased FGF8 signaling on gonadotropin-releasing hormone in humans and mice 
(178). However, there are few studies on FGF8 in TMJ during growth, development and bone 
remodeling. 
 FGF8 is required for cells that have undergone an epithelial-mesenchymal transition 
to move away from the primitive streak in mouse embryos (190). In FGF8 knockout mice the 
absence of embryonic mesoderm- and endoderm- derived tissues occurs due to the failure in 
cell migration. A disturbance in the patterning of the prospective neuroectoderm is also 
reported in FGF8 knockout mice. Furthermore, FGF8 has an important role in midbrain 
development (188) and cell patterning of the neural plate (191). FGF8 expression in the 
Nephrogenic Mesoderm (NM) is triggered by limb bud induction which seems to occur as a 
result of a signal from the Wolffian Duct (WD)4(192). In this position FGF8 is capable of 
inducing limb bud formation by acting on the lateral plate mesoderm (reviewed by Powers et 
al. 2000 (40)). 
           FGF8 is also widely expressed in the developing skeleton but its function has 
remained unclear. Adding the FGF8 to mouse bone marrow cultures effectively increases 
initial cell proliferation. In the cultures at an early stage of osteoblastic differentiation it also 
eases bone formation in vitro, which is also possible in vivo. In mouse bone marrow culture 
FGF8 regulates different stages of mesenchymal stem cell differentiation in the direction of 
                                                 
4 Wolffian Duct (WD) and the Nephrogenic Mesoderm (NM) are the components of the 
Intermediate Mesoderm (IM) which lies between the lateral plate mesoderm and the somites; 
IM is the normal source of the limb induction signal (Geduspan & Solursh 1992). 
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osteogenic lineage. It also increases the osteogenic capacity of bone marrow cells at the early 
stage of their differentiation; therefore, it may be involved in bone formation (165). 
 Several functions are reported for FGF8; regulation of cartilage formation in the 
vertebrate skull (193), involvement in cartilage and bone formation (concluded from its wide 
expression in the developing skeleton), influencing rib development (194), stimulating the 
avian chondrocytes (195) and cultured dental mesenchyme (196). The expression of core 
binding factor 1(cbfa; an osteoblast-specific transcription factor) in fibroblasts is induced by 
FGF8 and FGF2 (165, 197). 
 It is shown that FGF8 induces osteoblast differentiation. It is also able to efficiently 
stimulate the proliferation of cultured mouse bone marrow cells and to induce their early 
stage differentiation as a precondition for subsequent bone nodule formation and osteoblast-
specific alkaline phosphatase (ALP) production. FGF8 stimulates the proliferation of 
hypothetical osteogenic stem cells in bone marrow and tumours. It is conductive to their 
osteogenic potential, leading to osteoblastic differentiation and bone formation. However, 
continued exposure of osteoblastic cultures to FGF8 inhibits bone formation. (165). 
 During the development of chick limbs, FGF8 has effects on distal cartilage 
formation, synergistic with Indian Hedgehog (Ihh). It has a strong synergistic effect on 
promoting cartilage outgrowth with Sonic Hedgehog (Shh) during chick cranial development 
(198, 199), as well as a strong synergistic effect with Shh on chondrogenesis in vitro and 
promoting chondrogenesis in vivo, during early facial primordia development (198, 200). 
FGF8 is expressed in the beak primordial through much of the early to mid-development in 
the chick embryo and regulates the development of the beak in chick embryos, along with 
Shh. Rostral–ventral epithelium of the mandibular primordium (MP) is one of the distinct 
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domains in the developing head, where FGF8 is expressed during early to mid-stages of chick 
development.  
 Therefore, to localize the extent of chondrogenic skeletogenesis in the developing 
head, the limited expression domain of FGF8 could be important. FGF8 is able to induce 
chondrogenesis from the cranial neural crest. This is important since FGF8 could be a precise 
control key of localization and patterning of many cartilage and endochondral bone elements 
in the head (198). It is suggested that FGF8 signaling is required for the development of the 
distal cartilage element although it is indicated that FGF8 plays a role in the differentiation of 
mesenchymal cells (169).  
 FGF8 is a critical FGF ligand with FGFR1 and 2 as critical receptors in facial 
primordia. In this regard, common developmental disorders in human beings are facial clefts 
and insufficiency of craniofacial development (summarized by Nie et al 2006 (158)). 
However, the mechanism of mesenchymal cell proliferation and differentiation into 
chondrocytes is still unclear (169). In this field, FGF8 has also been studied in rabbit embryos 
(201) . Overall, FGF8 is an essential component in early craniofacial patterning and growth 
(158, 202). 
 On a molecular level, FGF signaling results in a chondrocyte proliferation decrease 
and an acceleration of chondrocyte hypertrophic differentiation (162). 
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Figure  2-8 FGF Genes Relative Expression 
 FGF genes relative expression pattern in forelimbs of mouse embryo (Modified from 
Minina et.al. 2005 (42)) 
 
 FGF8 subfamily members have higher relative activity on FGFR3c cells and less 
activity toward FGFR1c. The FGF8 subfamily is expressed in epithelial tissues and c splice 
forms of FGFRs are activated by FGF8. Therefore, FGF and FGFRs binding specificity is 
critical for the spatial regulation of FGF signaling. The below diagram shows relative activity 
of FGF8 with other FGF subgroups and FGF receptors(203). 
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 In mouse embryos, FGF8 is detected in tissues surrounding the developing bones such 
as the muscles and skin. Weak expression of FGF8 is also found at embryonic day 14.5 
(E14.5) in proliferating and early hypertrophic chondrocytes. It is weakly expressed in 
proliferating chondrocytes and in the bone (E16.5) (Figure 2-8). 
2.7. Proliferating Cell Nuclear Antigen (PCNA) 
 PCNA is a sliding clamp protein (a protein ring), found in all organisms in 
eukaryotes. The sliding clamp proteins are called the beta clamp in prokaryotes. These 
proteins form a ring around DNA. The sliding clamp, the DNA polymerases and a clamp- 
loading complex are the components of the ring type polymerases and their primary role is to 
replicate the genome, so they are also called replicases. Identical promoters form the sliding 
clamp that oligomerize to form a ring that encircles DNA (Figure  2-9) (44). 
 
Figure  2-9 PCNA 
(A) The sliding clamp ring in humans is constructed from two monomers to yield a ring 
composed of six domains. The inside diameter of the ring is about 35 Angstrom, allowing 
ample room to encircle the DNA. 
(B) In an ATP-driven reaction, a clamp-loader complex assembles the sliding clamp protein 
ring onto a primed template junction. The ring on the DNA then assembles with the DNA 
polymerase (Pol) to form a highly processive polymerase. The ring is pulled along behind 
the processive Pol while remaining tethered to DNA by the ring during chain extension 
(Modified from Bruck and O'Donnell, 2001; Genome Biology Vol 2 No 1 (44)). 
 
Sliding clamp - Clamp loader                       DNA Pol         
     (PCNA)                                                                           Processive Pol 
ATP 
ADP+Pi 
(A) Human PCNA                                          (B) ATP-driven reaction 
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 PCNA is originally characterized as a DNA polymerase accessory protein. It 
functions as a DNA sliding clamp for DNA polymerase delta. Furthermore, it is an essential 
component for eukaryotic chromosomal DNA replication. A striking feature of PCNA 
revealed in recent studies is its ability to interact with multiple partners; for example, 
PCNA’s roles in DNA repair, Okazaki fragment joining, DNA methylation and chromatin 
assembly. PCNA has applications as a marker for DNA synthesis, since these reactions 
mainly take place while replicating DNA (Abstracted by Tsurimoto et al 1999 (43)). 
 PCNA, a well-known cell cycle marker protein, was originally identified as an antigen 
for autoimmune disease in systemic lupus erythematosis patients (204). Its involvement in 
DNA replication is suggested due to periodic appearances in S phase nuclei, co-localized 
with incorporated bromodeoxyuridine (205, 206). Indeed, PCNA as an essential factor for 
SV40 (Simian Virus 40) DNA replication was later identified in vitro (207). Additionally, it 
is demonstrated that PCNA is essential for chromosomal DNA replication in biochemical and 
genetic studies with budding yeast (208-210). It is also analogous to the Pol III beta-subunit 
and the T4 gene45 protein (encircles DNA and freely slides along DNA with its closed ring 
structure), functioning as a DNA sliding clamp (211). PCNA gene expression is associated 
with cell proliferation and the promoter sequence contains binding sites for many 
transcription factors (44). 
 There are specific interactions between PCNA and several DNA repair-related gene 
products (212). PCNA is involved in both mismatch repair and excision in eukaryotes (44). It 
is required for DNA synthesis during replication, for DNA repair, DNA recombination-
driven synthesis and post-replicative DNA processing (213). 
 PCNA is not only a clamp to a master molecule for chromosome processing but is 
also a necessity for all organisms as the existence of a DNA sliding clamp. However, during 
63 
 
evolution, clamp molecules gained an increasing number of functions. Indeed, PCNA binding 
proteins have only been identified in mammalians and they are active in cell cycle regulation 
or replicated chromosome reorganization (43). 
 PCNA is immunocytochemically detectable during the late G1- and S-phases (214). It 
is an established method to study the proliferation activity of cells with specific antibodies in 
developmental processes and clinical studies (215-217). PCNA-positive cells are mainly 
present in the proliferative zone in the condyle (47, 98). Furthermore, detected PCNAs in the 
deeper layer of condyle could indicate that proliferation, to some extent, remains active in 
hypertrophic chondrocytes. 
 Therefore, PCNA is an indicator for cellular proliferative activity in tissue organs (46, 
47, 198, 218-220) and in the current study it is detected in the MCC to quantitatively evaluate 
the proliferative activity in the condyle during mandibular advancement.
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3. Methods and Materials  
3.1. Animals and experimental design 
 Fifty five female Sprague Dawley rats at the age of 24 days were randomly divided 
into the experimental group (n = 35) and the control group (n = 20); the study was approved 
by Westmead Animal Ethical Committee (Protocol No: 4113.06-08). The animals were 
housed five per cage at the Westmead Hospital’s animal laboratory unit. All of the rats were 
kept in the same well-controlled temperature and humidity environment. They were fed a soft 
palate diet and they had uninhibited access to water 24 hours a day throughout the entire 
experimental period. 
 According to the planned experiment, on day 3, day 14, day 21 and day 30 the 
animals were further divided into four experimental subgroups (10 rats each in groups 1, 2 
and 3, and 5 rats in group 4) and four control subgroups with 5 rats each. The bite-jumping 
appliance was placed on the 24 day-old experimental rats to induce mandibular advancement 
at Day 0. Rats were 21 days-old at their arrival to the animal laboratory. The first three days 
were assigned for the initial settlement of the rats into the new environment of the animal 
laboratory. 
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Table  3-1 Experimental Design 
Experiment 
Days 
Rats Age 
(Days)* Study Criteria 
Day 0 24 Days  (No sacrifice) 
Entry to the experiment, random grouping  and 
laboratory initial settlements 
 
Age at the day 
of sacrifice 
Experimental 
Group  
(35 rats) 
Control  
Group  
(15 rats) 
Total sacrificed 
samples (55 rats) 
Day 3  27 Days 10 rats 5 rats 15 rats 
Day 14  38 Days 10 rats 5 rats 15 rats 
Day 21  45 Days 10 rats 5 rats 15 rats 
Day 30  54 Days 5 rats 5 rats 10 rats 
∗ Female Sprague-Dawley rats were collected for the study; approved by Westmead 
Animal Ethical Committee. 
 
3.1.1. Anaesthesia and Appliance fitting 
The animals were sedated with ketamine hydrochloride (Ketavet®, Delvet, NSW 
Australia) and xylazine hydrochloride (Ilium Xylazil-20®, Troy Laboratories, NSW, 
Australia).  
 The lower anterior incisors were washed and dried. The teeth were coated by 
Transbond™   Plus  Self Etching Primer (3M Unitek, Monrovia, California) evenly through 
the whole surfaces and pediatric crown former (3M™ ESPE™ Strip Crown Form Refills, 
USA) were adjusted on the lower incisors with light cure composite (3M™ ESPE™ Z100™ 
Restorative dispenser for capsule, USA). The crown former was positioned in such a way that 
it caused mandibular forward-downward positioning during the rats’ rest and functional bite 
(Figure  3-1B). The animals in the control groups were not fitted with an appliance and were 
untreated (Figure  3-1A). Body weight was monitored throughout the experiment. 
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Figure  3-1 Bite Jumping Appliance 
(A) Normal incisal relationship in control rats. 
(B) Bite-jumping appliance is adjusted on the lower incisors of experimental rats to move 
their mandible into a forward position during rest and function. 
 
3.1.2. Weight gain recording 
 The weight was recorded at the beginning of the experiment and the day of sacrifice. 
The weight was recorded to evaluate and compare the somatic growth status between 
experimental and control samples. 
3.2. Euthanasia and Tissue Preparation 
 The animals in each subgroup were euthanized respectively, by Carbon Dioxide Gas 
(Aligal 2, Air Liquid, Australia) on days 3, 14, 21 (10 experimentals and 5 controls on each 
day) and Day 30 (5 experimentals and 5 controls) of the experiment which were the 27th, 38th, 
45th and 54th day of the rats’ age. 
 Immediately after death, the heads were removed and fixed in 4% paraformaldehyde 
for 24 hours. The method of making one liter of 4% paraformaldehyde was based on the 
histology laboratory manual at the Institute of Dental Research (IDR), Westmead Hospital, 
NSW, Australia; the fixative solution should be prepared fresh each time before use.  
 The aim of the fixation is the coagulation or precipitation of the substances making up 
the protoplasm; e.g. proteins, lipids, carbohydrates and inorganic salts. This process renders 
    A     B 
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the cells, tissues and their elements resistant to further changes prior to microscopic 
examination. Its effects are to penetrate tissues and kill them quickly, preserve all tissue 
elements, and to harden the tissues so they will not be affected by the subsequent 
dehydration, cleaning, impregnation, embedding, staining and other preparative processes.  
 The heads were then decalcified in 20% ethylene-diamine-tetra-acetic acid (EDTA), 
pH 7-7.4, at 4-8°C for 4–6 weeks. It is made of 100mg EDTA powder, 50ml PBS and 400ml 
distilled water plus 100-130 NaCl tablets for 500ml 20% EDTA, PH 7-7.4.  
 The TMJ was dissected and the surrounding soft tissues were removed until the TMJ 
was exposed. Excess tissues were removed and the specimens with the buccal surface of 
ramus parallel to the surface of the block were embedded in paraffin. 5 μ thick serial sections 
were cut through the TMJ at the parasagittal plane using a rotary microtome (Leitz 1516, 
Leica Microsystems, Wetzlar, Germany); sectioning was continued until approximately 
reaching the middle of the condyle. At that level a few sections were floated onto glass slides 
coated with Poly L Lysine.  
 Individual variations occur in the TMJ orientation in the skull. Thus, in order to make 
a reliable comparison, the plane of each section throughout each of these anatomic variables 
was adjusted as identically as possible between samples. The sections cut from each sample 
were assigned to the immunohistochemical staining for FGF8 and PCNA. 
3.3. Immunohistochemical examinations 
 The specific primary antibodies used were FGF-8 goat polyclonal antibody collagen 
(N-19, cat#sc-6958, Lot#E300, 200 μg/ml, Santa Cruz Biotechnology, USA) and Mouse 
PCNA Unconjugated Purified antibody with multiple reactivity (200 µg, catalogue# 13-3900, 
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mouse anti-PCNA; Zymed®; RUO, supplied by Invirogen). The secondary antibodies were 
rabbit -anti- goat IgG (HRP, Code No.P0449, Dako A/S, Denmark) for FGF-8 and for PCNA. 
 Immunohistochemistry was carried out using a method in which, after the sections 
were dewaxed and rehydrated, were treated with glycine (1 in 10 phosphate buffer solution 
(PBS)) and then in 3% hydrogen peroxide (1 in 10 PBS) for 5 minutes to retrieve the antigen. 
Non-specific bindings were blocked with horse serum (1 in 5 PBS) for 45 min. Then the 
samples were incubated with the primary antibody (1 in 50 fetal calf serums (FCS)) for 120 
minutes. Free antibodies were removed by washing the samples in a phosphate buffer 
solution (PBS) thoroughly. After washing, sections were incubated with the secondary 
antibody (1 in 100 FCS) for 30 minutes, followed by washing.  
 Then the slides were dipped in 3, 3’-diaminobenzidine (DAB) in chromogen solution 
(Dako Liquid DAB+ Substrate Chromogen System, Code K3467, Denmark) for 6 minutes to 
identify the binding sites. Sections were finally counterstained with Mayer’s Hematoxylin for 
background staining. Negative controls were included, on which the primary antibody was 
replaced by FGF-8 blocking peptide (N-19 P, cat#sc-6958 P, Lot# F268, 100 μg/0.5ml, Santa 
Cruz Biotechnology, USA) to ascertain the specificity of the immunostaining. 
 The slides were covered by Mounting Medium (Fisher Scientific Permount, for 
mounting and storage, SO-P-15, 500 ml-1.1 pt., USA) and a cover slip for long term storage 
of slides and further microscopic studies. 
 The slide preparation could be summarised as follow: 
1. Heating in the dry oven for 30-45 minutes. 
2. Washing in running distilled water. 
3. Dewaxing; floating the slides in Histoclear for 2x5 minutes, 100% Ethanol for 2x2 
minutes, 95% Ethanol for 2 minutes and 70% Ethanol for 2 minutes. 
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4. Washing in running distilled water. 
5. Covering the tissue with Glycine (1 in 10 PBS) for 10 minutes. 
6. Rinsing with PBS. 
7. Covering the tissue with 3% Hydrogen Peroxide ((OH) 3%, 1 in 10 PBS) for 5 minutes. 
8. Rinsing with PBS. 
9. Covering the tissue with Horse Serum (1 in 5 PBS) for 45 minutes. 
10.  Rinsing with PBS. 
11. Primary antibody and blocking peptide; 
11.1. Covering the tissue with primary antibody (1 in 50 FCS) for 2 hours. 
11.2. For preparing negative controls, instead of primary antibody, one piece of 
tissue section on each slide were covered by blocking peptide (1 in 10 FCS) for 2 
hours while the other section was normally incubated by primary antibody; on each 
slide there were two pieces of tissue from two slices next to each other. 
12. Rinsing with PBS and floating the slides in PBS for 3x5 minutes. 
13. Covering the tissue with secondary antibody (1 in 100 FCS) for positive staining for 
FGF8 or PCNA for 1 hour. 
14. Rinsing with PBS and floating the slides in PBS for 3x5 minutes. 
15. Covering the tissue with DAB+ for 6 minutes. 
16. Washing in running water. 
17. Floating the slides in Hematoxylin for 3-5 seconds.   
18. Floating the slides in water for few seconds, until the water becomes homogenously 
blue.   
19. Clearing the slides by floating them in Histoclear and Ethanol in seven different dishes, 
1 minute each; 70% Ethanol, 90% Ethanol, 95% Ethanol, 100% Ethanol and then in 
three separate dishes of Histoclear.   
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20. Covering the tissue by Mounting Medium and cover slip; 
These slides are prepared for microscopic studies and long term storage. 
 
3.4. Quantitative imaging and statistical analysis 
 Digital images were taken from stained tissues with a Leica digital imaging 
microscope and its software (Leica application suit software) by 10 times, 20 times and 60 
times magnification. The unified area for microscopic image-taking is shown in figure 3-2.  
 The expressions of FGF8 and PCNA were quantified by manually counting the cells 
of positive reacted immunostaining signals on the computer screen from the 20 times 
magnified images. The cells were counted from the middle quarter of the MCC and distal 
third of the GF, where the most prominent cellular responses to mandibular repositioning 
occur (6, 11, 148). The cells which were stained with certain intensity were counted and those 
which were weakly stained were excluded. 
The repeatable counting method used in this study is summarised as follows: 
1. Cropping the middle quarter of the MCC and distal third of the GF from the 20 
times magnified microscopic images with the software, Microsoft Office Picture 
Manager 2007. 
2. Transferring the cropped piece of the image to the Adobe Photoshop CS software 
and putting dots on typically stained cells. 
3. Then counting the cells in a directed order. 
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Figure  3-2 the unified area for image taking 
(A) The schematic view of the rat’s TMJ is drawn by following the anatomic outlines of the 
condyle and the GF. The condyle, articular disc (AD), the glenoid fossa (GF) and the 
articular eminence (AE) are drawn with hard lines and the outer and inner limits of the 
soft tissues are approximately shown by heavy and light dashes. 
(B) The images are taken from the unified areas for all samples. The boundaries of different 
magnifications are shown with red (10x), blue (20x) and green (60x) squares on the 
most distal and superior part of the condyle and the most distal part of the GF. The 
unified areas on the condyle are approximately from 9-12 o-clock for 10x, from 10-11 
o-clock for 20x and between 10 and 11 o-clock for 60x. 
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Figure  3-3 HRP positive immunostained cell counting in MCC and GF 
(A) The GF of a 38 day-old Sprague Dawley rat from group 3, experimental. Horse radish 
peroxidase (HRP) positive stained cells for FGF8 are brown. 
(B) The distal third of the section (A) in which the heavily stained cells are marked with 
dark green dots for cell counting. 7 dots are counted in this section. 
(C) The MCC of a 45 day-old Sprague Dawley rat from group 3, control. HRP positive 
stained cells for FGF8 are brown. 
(D) The middle quarter of the section (C) in which the heavily stained cells are marked with 
dark green dots for cell counting. 36 dots are counted in this section. 
 
After the first counting, the data were collected again four weeks later by the same 
observer and the Method of error (ME) was tested by using the formula: 
ME= 
n
d
2
2∑  
In this formula, “d” is the difference between the two registrations of a pair and “n” is the 
number of double registrations. For ME analysis ten readings were randomly drawn. Paired t 
tests were used to compare the two registrations. There was no statistically significant 
A B 
C 
D 
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difference   among the registrations. Data were analysed using a statistical package (SPSS for 
Windows Version 16.0; SPSS, Chicago, IL). 
 The ANOVA (Analysis of Varience) statistical evaluation for each of the FGF8 and 
PCNA antibodies was carried out using day and appliance as factors and weight at sacrifice 
(wts) as a covariate, although to some extent the effect of weight at sacrifice is 'captured' by 
day. A day by appliance interaction was included if it was significant but dropped if 
otherwise. Not surprisingly, day was significant for all antibodies; weight at sacrifice was 
significant for only some.  
 
 
 
 
 
  
 
 
 
RESULTS 
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4. Results 
Table  4-1 The whole experiment’s details and recorded data for each sample 
Group 1 
Experiment 
Number of immunopositive stained 
cells for FGF8 and PCNA** Weight  
Reference Experiment Day of Sac 
Age 
(Days) Group Appliance *** Class**** FGF8c  FGF8gf  PCNAc PCNAgf  Initial weight 
Weight at 
Sacrifice 
(wts) 
201* 3 27 1 1 II 20 19 20 30 79.6 84 
202 3 27 1 1 II 25 13 41 31 93.5 97 
203 3 27 1 1 III 28 18 37 n/a 75.3 108 
204 3 27 1 1 II 27 16 63 32 92.2 102 
205 3 27 1 1 III 16 15 36 21 91 97 
206 3 27 1 1 III 19 19 22 12 87.5 96 
207 3 27 1 1 III 22 18 54 20 92.2 104 
208 3 27 1 1 III 24 n/a n/a 13 81.2 84 
209 3 27 1 1 III 18 21 55 23 95.9 102 
210 3 27 1 1 III 22 19 36 20 85.7 86 
111 3 27 1 0 I 15 12 20 24 91.3 100 
112 3 27 1 0 I n/a 8 68 18 90.6 100 
113 3 27 1 0 I 20 10 23 n/a 81 111 
114 3 27 1 0 I 14 15 24 8 89 115 
115 3 27 1 0 I 17 9 33 9 85 110 
 
Table 4-1 The whole experiment’s details and recorded data for each sample 
Group 2 
 
Experiment Number of immunopositive stained cells for FGF8 and PCNA** Weight  
Reference Experiment Day of Sac 
Age 
(Days) Group Appliance*** Class**** FGF8c  FGF8gf  PCNAc PCNAgf  Initial weight 
Weight at 
Sacrifice 
(wts) 
216 14 38 2 1 II 79 3 41 16 96.4 153 
217 14 38 2 1 III 78 1 52 22 90.2 146 
218 14 38 2 1 III 76 2 38 19 93.3 158 
219 14 38 2 1 II 71 4 43 22 97.4 156 
220 14 38 2 1 III 73 8 79 20 100.7 154 
221 14 38 2 1 III 64 1 63 10 96.7 164 
222 14 38 2 1 II 69 1 65 10 85.5 154 
223 14 38 2 1 III 73 0 n/a 15 98.1 144 
224 14 38 2 1 III deviated to the right 67 7 44 14 95.6 145 
225 14 38 2 1 II 77 2 36 11 83.7 130 
126 14 38 2 0 I 63 1 31 14 98.1 159 
127 14 38 2 0 I 61 2 63 15 90.4 153 
128 14 38 2 0 I n/a 2 80 15 89.2 150 
129 14 38 2 0 I 61 0 34 13 101.1 166 
130 14 38 2 0 I 60 0 32 12 n/a 157 
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Table 4-1 The whole experiment’s details and recorded data for each sample 
Group3 
 
Experiment Number of immunopositive stained cells for FGF8 and PCNA** Weight  
Reference Experiment Day of Sac 
Age 
(Days) Group Appliance*** Class**** FGF8c  FGF8gf  PCNAc PCNAgf  Initial weight 
Weight at 
Sacrifice 
(wts) 
231 21 45 3 1 III 45 n/a 96 8 93.4 155 
232 21 45 3 1 Appliance broke and came off 56 1 80 11 91.6 160 
233 21 45 3 1 II 63 1 103 11 88.7 149 
234 21 45 3 1 II 58 0 64 12 91.3 174 
235 21 45 3 1 III 49 0 30 n/a 99.9 180 
236 21 45 3 1 III 47 0 79 21 97.6 135 
237 21 45 3 1 III 50 0 170 6 94.3 163 
238 21 45 3 1 III 45 0 100 14 91.3 164 
239 21 45 3 1 II 60 1 120 13 91.7 178 
240 21 45 3 1 Appliance broke and came off 48 0 117 10 92.2 157 
141 21 45 3 0 I 51 1 74 1 87.5 175 
142 21 45 3 0 I 46 n/a 72 6 n/a 172 
143 21 45 3 0 I 41 0 80 8 86.7 161 
144 21 45 3 0 I 39 0 110 2 90 178 
145 21 45 3 0 I 42 0 110 7 94.3 185 
 
Table 4-1 The whole experiment’s details and recorded data for each sample  
Group 4 
Experiment Number of immunopositive stained cells for FGF8 and PCNA** Weight  
Reference Experiment Day of Sac 
Age 
(Days) Group Appliance *** Class**** FGF8c  FGF8gf  PCNAc PCNAgf  Initial weight 
Weight at 
Sacrifice 
(wts) 
246 30 54 4 1 III 27 1 78 1 84.4 168 
247 30 54 4 1 II 30 0 160 0 91.1 182 
248 30 54 4 1 III 23 0 72 5 100 177 
249 30 54 4 1 II 20 1 76 11 97.1 180 
250 30 54 4 1 III 25 1 90 0 97.7 158 
151 30 54 4 0 I 26 1 57 2 92.1 205 
152 30 54 4 0 I 23 0 52 4 92.3 215 
153 30 54 4 0 I 27 0 62 1 96 214 
154 30 54 4 0 I 30 0 60 n/a 87.1 180 
155 30 54 4 0 I n/a n/a 41 n/a 93.2 218 
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*          In the reference column, the first digit 1 stands for control samples and 2 stands for 
experimentals. The next two digits are the particular number for each sample from 1 (the first 
experimental rat in group 1) to 55 (the fifth control rat in group 4). 
**         In each slide, the cells which were positively immunostained for the FGF8 or PCNA 
were counted. The cells with a stain that was not certainly intense were excluded.   
***       In the appliance column, 1 stands for samples wearing bite-jumping appliance and 0 
stands for samples without an appliance. 
****     In the class column, Type of occlusion is reported due to the upper and lower incisors 
relationship. I stands for Cl I; lower incisors were located behind the upper in contact with 
the lingual surface of the upper incisors (which is observed in all control samples). II stands 
for Cl II; lower incisors were located behind the lingual surface of the upper incisors, further 
backward with no contact due to the bulk of the bite-jumping appliance. III stands for Cl III; 
lower incisors were positioned in front of the upper incisors, which is comparable to the 
human Cl III incisal relationship. 
 
4.1. Histological Structures 
 The five distinctive cellular layers and the bone of the MCC and the GF are shown in 
figures 4-1 and 2-3. The articular layer is the most superficial layer with small, globular, 
densely distributed mesenchymal cells. The articular surface of the MCC and the articular 
surface of the GF are basically similar. They are covered by a layer of dense fibrous tissue 
which is the Articular Zone (A).  
 Underneath the fibrous layer, there is an undifferentiated mesenchymal cell zone. The 
undifferentiated reserve cells are dense and packed together. The underlying layer is the 
resting layer (R). Prechondroblasts beneath the resting layer are known as the Proliferative 
Zone (P).  
 The next layer is the Hypertrophic Zone which is accommodated with chondroblasts. 
Mature chondrocytes are deep in this layer (H). The Erosive layer is further down where 
highly hypertrophic chondrocytes are broken down and their surrounding matrices are 
degenerated (E). The frontier of the newly formed bone is beneath the erosive layer (B) (17). 
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Figure  4-1 Distinctive cellular layer in the MCC and the GF 
The GF (I) and the MCC (II) of an experimental sample (27-day old Sprague Dawley 
rat wearing bite-jumping appliance for 3 days), immunostained for FGF8; GF (III) and the 
MCC (IV) of a control sample (45-day old Sprague Dawley rat without orthodontic 
appliance), negative control slide for a FGF8 immunostained slide;  Different cellular layers 
in the MCC and the GF named as A-Articular Zone, R-Resting Zone, P-Proliferating Zone, 
H-Hypertrophic Zone (arrow (I)), E-Erosive Zone and CO-Connective tissue-Osteoblasts 
(arrow (III)). The thickness of cartilage indicates the dominance of endochondral ossification, 
except in image (III)-CO, in which the Hypertrophic and Erosive zones are replaced with 
Connective tissue and Osteoblasts. This suggests the dominance of intramembranous 
ossification in female Sprague Dawley rats after 5-7 weeks of age or it implies that the active 
growth and development of their GF is until 5-7 weeks of age (10, 17, 22, 64, 130, 131, 148). 
4.2. FGF8 Expressions in the Mandibular Condylar 
Cartilage (FGF8c) and the Glenoid Fossa (FGF8gf) 
 The FGF8 was mainly expressed in the early hypertrophic layer and hypertrophic 
layer of the MCC and GF in the control and experimental groups (42, 45). 
 The level of FGF8c progressively increased from Day 3 to Day 14 in the MCC, after 
which the expression declined gradually until Day 30. However, the level of FGF8gf 
expression in the GF progressively decreased from Day 3 to Day 14, followed by a slight 
decrease from Day 14 to Day 21 and a little increase on Day 30. The level of increase from 
              A  R    P               H               E       B 
20X(II) 
    A       R     P                 H               E        B 
20X(IV) 
                  A      R         P     CO                     B 
20X(III) 
       A     R       P           H       E                    B 
20X(I) 
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Day 21 to Day 30 was still significantly lower than the same measurement on Day 14 (Figure 
4-4). 
 In the experimental samples generally the expression of FGF8 in response to 
mandibular advancement in both the MCC and the GF is significantly higher than control 
groups (p=002) (Table  4-2, Figure  4-3). However, there was an exception on Day 30 for the 
MCC which the amount of FGF8 expression in control group was non-significantly higher 
than experimental group (Table  4-2). Over all, the level of FGF8 expression was remarkably 
higher in the MCC than GF (Table  4-2, Figure  4-3, Figure 4-4).  
 The pattern of expression in experimental groups and Control groups for each tissue 
was similar, but the pattern of expression in the MCC was different from the one in the GF. 
The pattern of expression across the MCC led to a maximum expression on Day 14 followed 
by a gradual decrease, while the maximum expression in the GF was on Day 3 followed by a 
significant severe decrease on Day 14 followed by a light decrease toward the end of the 
experiment. The little increase from Day 21 to Day 30 could be omitted as it is a non 
significant change plus considering a very low level of FGF8 expression. The important 
results were that generally the effect of appliance is significant for FGF8 in the GF and the 
MCC (FGF8c, p=0.002 and FGF8gf, p=0.002) (Table  4-2, Figure  4-3, Figure 4-4).  
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Figure  4-2 FGF8 in the MCC and the GF 
Photograph of a female Sprague Dawley rat’s TMJ (A) shows the anatomic 
relationship of the condyle (A-MCC) and the articular fossa (A-G) and the arrow (A) shows 
the direction of forward-downward displacement of the condyle during mandibular 
advancement. Photomicrographs show immunostaining for FGF8 expressed in and the GF of 
another experimental sample (27-day old rat, wearing bite jumping appliance for 3 days) (B, 
C and D) and the MCC of an experimental sample (38-day old rat, wearing bite jumping 
appliance for 14 days) (E, F, and G);The cytoplasm of early hypertrophic and hypertrophic 
cells, beneath the layer of cell proliferation and above the erosive zone were positively 
stained for FGF8 (arrow (D, G)). FGF8 is mainly located in cytoplasm of osteo-
chondroprogenitor cells, chondroblasts and chondrocytes before their degeneration, which is 
shown by extra magnification of a typical immunopositive-cell for FGF8 from the 
hypertrophic layer of the MCC of a 38-day old experimental sample (H). The location of 
FGF8 expression was consistent with other reports which suggest that FGF8 could be known 
as an indicator for osteogenesis through an endochondral ossification process by patterning 
and regulating the chondrocytes’ proliferation and their hypertrophic morphological 
differentiation (42, 158, 162). For more images see appendix 1, section FGF8c and FGF8gf. 
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Table  4-2 FGF8 c & gf; Experimentals vs. Controls 
               Quantitative analysis of FGF8 expression in Condylar Cartilage (FGF8c) and 
Glenoid Fossa (FGF8gf). The number of FGF8 immunopositive cells is considered for 
calculating the values and statistical analysis of experimental samples versus controls. This 
indicates the overall effect of the bite jumping appliance on the level of FGF8 expression. 
    95% Confidence Interval 
 Group Mean(No.) Std. Error Lower Bound Upper Bound 
Condylar Cartilage 
(FGF8c) 
Control 37.121a 1.451 34.194 40.047 
Experimental b 42.952a .852 41.233 44.671 
Glenoid Fossa 
(FGF8gf) 
Control 3.088a .573 1.933 4.244 
Experimental b 5.345a .349 4.641 6.050 
a. Covariates appearing in the model were evaluated at the following values: wts = 148.077(c) & 147.824 (gf) 
b. P=0.002 (The effect of  the appliance was statistically significant for FGF8c & FGF8gf) 
 
 
 
 
 
 
 
 
 
Figure  4-3 FGF8 c & gf; diagram for Experimentals vs. Controls 
In this diagram the mean of the number of FGF8 immunopositive cells in the MCC 
(FGF8c) and Glenoid Fossa (FGF) are compared in experimentals and controls. The level of 
FGF8 expression in experimentals’ condyle and the GF was significantly higher than their 
relevant control samples (p=0.002). Furthermore, the diagram clearly shows that the amount 
of cellular activity in the MCC was greatly higher than GF in both controls and 
experimentals. 
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Table  4-3 FGF8 c & gf; Experimentals vs. Controls in different experiment days  
        Quantitative analysis of FGF8 expression in Condylar Cartilage (FGF8c) and Glenoid 
Fossa (FGF8gf). The number of FGF8 immunopositive cells is considered for calculating the 
values and statistical analysis of experimental samples versus controls in different experiment 
days. This indicates the effect of the bite jumping appliance on the level of FGF8 expression 
in different stages of rat’s growth. 
 Group a, b Day 3 Day 14 Day21 Day 30 
Condylar Cartilage Exp. c 21.676a±3.798 72.719a ± 1.494 52.209a ± 1.738 25.203a ± 2.686 
 95% CI 14.017, 29.336 69.706,  75.732 48.705, 55.713 19.786 ,  30.619 
 Cont. 16.182a±3.521 61.337a ±2.456 44.012a ±2.737 26.951a ±4.400 
 95% CI 9.081, 23.283 56.384, 66.290 38.494, 49.531 18.078, 35.823 
Glenoid Fossa Exp. b 17.503a±1.526 2.903a ± 0.607 0.348a ± 0.749 0.626a ±1.098 
 95% CI 14.424, 20.583 1.678,  4.128 -1.162,  1.859 -1.590 , 2.842 
 Cont. 10.758a±1.405 1.010a ±0.889 0.278a ±1.207 0.308a ±1.803 
 95% CI 7.923, 13.592 -0.785 , 2.804 -2.157 , 2.713 -3.330 , 3.945 
a. Data were presented as M ± SE (Standard Error)(No.); CI: Confidence Interval- Lower, Upper 
b. Covariates appearing in the model were evaluated at the following values: wts = 148.077(c) & 147.824 (gf)  
c. p=0.002; The effect of  the appliance was statistically significant for FGF8c & FGF8gf. 
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Figure  4-4 FGF8 c & gf; diagram for experimentals vs. controls in different experiment 
days 
 In this diagram the mean of the number of FGF8 immunopositive cells in the MCC 
(FGF8c) and the GF (FGF8gf) were compared in experimentals and controls in different 
experiment days. The level of FGF8 expression in experimentals’ condyle and GF generally 
was significantly higher than their relevant control samples. Furthermore, it was clear that the 
amount of cellular activity in the MCC is greatly higher than the GF in both controls and 
experimentals in different stages of growth and development.  
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For more details and diagrams on statistical analysis see appendix 2, section FGF8c 
and FGF8gf. 
4.3. PCNA Expressions in Mandibular Condylar 
Cartilage 5 (PCNAc) and Glenoid Fossa (PCNAgf) 
 The PCNA was expressed mainly in proliferative cellular layer during normal growth 
and adaptive response to mandibular protrusion in the MCC and the GF (Table  4-4) (42, 45). 
 The level of PCNA expression gradually increases from Day 3 to a maximum 
expression on Day 21 in the MCC after which the expression declines on Day 30. However, 
the level of expression of PCNA gradually decreases from Day 3 towards the end of the 
experiment in the GF (Table  4-5, Figure  4-7).  
 In the experimental samples generally the expression of PCNA in both MCC and GF 
in response to mandibular advancement was higher than control groups. The level of extra 
PCNA expression in the MCC was not statistically significant (p=0.327) but it was 
significant in the GF (Table  4-4). Generally, the level of PCNA expression was remarkably 
higher in the MCC than the GF (Table  4-4, Figure  4-6).  
 The pattern of expression in experimental groups and control groups for both of 
condyle and the GF was similar, but the pattern of expression in the MCC was different from 
the one in the GF. The pattern of expression across the MCC led to a maximum expression on 
Day 21 followed by a decrease on Day 30, while the maximum expression in the GF was on 
Day 3 followed by a gradual drop toward the end of the experiment. The important results 
                                                 
5 The data and images of PCNA - Condylar Cartilage are transferred from Dr. Zoe Potres’ study on the same 
samples using the same methods and materials, perusing her MPhil degree through the project. It is reported 
here for consistency and completeness of the current part of the text followed by a more coherent discussion and 
conclusion.   
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were that the effect of appliance in the GF and in the MCC was not significant for PCNA 
(PCNAgf, p=0.327- PCNAc, p=0.327). 
          
   
   
Figure  4-5 PCNA in Condylar Cartilage and Glenoid Fossa 
Photograph of a female Sprague Dawley rat’s TMJ (A) shows the anatomic 
relationship of the condyle (A-MCC) and the GF (A-GF) and the arrow (A) shows the 
forward-downward displacement of the condyle during mandibular protrusion. 
Photomicrographs show immunostaining for PCNA expressed in the GF of another 
experimental sample (27 day-old rat, wearing bite-jumping appliance for 3 days) (B, C and 
D) and the MCC of an experimental sample (45 day-old rat, wearing bite-jumping appliance 
for 21 days) (E, F, and G); The nucleus of proliferative cells, beneath the resting zone and 
above the hypertrophic zone, were the majority of PCNA immunopositive cells (arrow (D, 
G)). PCNA was located mainly in the nucleus of the mesenchymal cells and osteo-
chondroprogenitor cells during their active proliferation, which is shown by extra 
magnification of a typical immunopositive cell for PCNA from the hypertrophic layer of the 
MCC of a 38 day-old experimental sample (H). As expected, the location of PCNA detection 
was consistent with other reports introducing the PCNA as an indicator for cells’ active 
proliferation and PCNA immunopositive nucleuses in other layers could suggest that some 
cells were still dividing beside morphologic and degenerative changes of the other cells in a 
particular  cellular zone (1, 22, 43-47, 221) 
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Table  4-4 PCNA c & gf; Experimentals vs. Controls 
               Quantitative analysis of PCNA detection in Condylar Cartilage and Glenoid Fossa. 
The number of PCNA immunopositive cells is considered for calculating the values and 
statistical analysis of experimental samples versus controls. This indicates the effect of the 
bite-jumping appliance on the level of cellular proliferation in general. 
    95% Confidence Interval 
 Group Mean(No.) Std. Error 
Lower 
Bound 
Upper 
Bound 
Condylar 
Cartilage Control 59.012
a 6.595 45.745 72.728 
 Experimental b 68.364a 4.499 59.313 77.414 
Glenoid Fossa Control  8.866a 1.604 5.632 12.099 
 Experimental c 13.498a .935 11.614 15.382 
a. Covariates appearing in the model were evaluated at the following values: wts = 
149.811(c ),147.420(gf) 
b. P=0.327; The effect of  the appliance was not statistically significant for PCNA in the 
Condyle (PCNAc) 
c. P=0.327; The effect of  the appliance was not statistically significant for PCNA in the GF 
(PCNAgf) 
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Figure  4-6 PCNA c & gf; diagram for Experimentals vs. Controls 
In this diagram the mean of the number of PCNA immunopositive cells in the MCC 
and in the GF were compared in experimentals and controls. The level of PCNA expression 
in the experimentals’ GF was not significantly higher than their relevant control samples. It 
was also not statistically significantly higher in the experimentals’ MCC. Furthermore, the 
diagram clearly shows that the amount of cellular proliferation in the MCC was greatly 
higher than in the GF in both controls and experimentals.  
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Table  4-5 PCNAc & gf experimentals vs. controls on different experiment days  
        Quantitative analysis of PCNA expression in Condylar Cartilage and Glenoid Fossa. The 
number of PCNA immunopositive cells is considered for calculating the values and statistical 
analysis of experimental samples versus controls on different experiment days. This indicates 
the effect of the bite-jumping appliance on the level of cellular proliferation expression in 
different stages of rat’s growth. 
 Group a, b Day 3 Day 14 Day21 Day 30 
Condylar  Exp. c 42.941a±20.049 51.160a ±8.219 95.344a ±8.787 94.097a ±13.658 
Cartilage 95% CI 2.536,83.347 34.597,67.724 77.635,113.052 66.570 , 121.623 
 Cont. 35.628a±18.489 47.658a ±11.291 88.040a ±13.910 51.707a ±22.590 
 95% CI -1.634, 72.889 24.902,70.414 60.006,116.073 6.181,97.234 
Glenoid Fossa Exp. b 20.433a±4.763 16.014a±1.646 12.236a±1.992 4.375a±3.153 
 95% CI 10.813, 30.053 12.689, 19.339 8.214, 16.259 -1.991, 10.742 
 Cont. 13.180a±4.318 14.165a±2.438 5.821a±3.222 4.770a±6.149 
 95% CI 4.459, 21.901 9.241, 19.090 -0.687, 12.329 -7.648, 17.189 
a. Data were presented as M ± SE (Standard Error) (No.); CI: Confidence Interval-Lower, 
Upper 
b. Covariates appearing in the model were evaluated at the following values: wts = 
149.811(c) & 147.420 (gf) 
c. P=0.327; The effect of  the appliance was not statistically significant for PCNA in the 
Condyle (PCNAc) 
d. P=0.327; The effect of  the appliance was not statistically significant for PCNA in the GF 
(PCNAgf) 
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Figure  4-7 PCNA c & gf; diagram for experimentals vs controls on different experiment 
days 
 In this diagram the mean of the number of PCNA immunopositive cells in the MCC 
and the GF were compared on different experiment days. The level of detected PCNAs in the 
samples’ MCC and GF indicates that the amount of cellular proliferation in the MCC was 
greatly higher than in the GF during different stages of the rats’ growth and development. 
Additionally, the pick of proliferative activity in the MCC and GF shows that the progenitor 
cells’ dividing slowed down after 45 days of rats’ age in the condyle and after 27 days of age 
in the GF with different patterns of expression. The changes were significant on different 
days of experiment. 
 For more details and diagrams on statistical analysis see appendix 2, section PCNAc 
and PCNAgf. 
4.4. Mandibular Position 
 The control groups had normal Cl I relationship without any appliances. The bite- 
jumping appliances were adjusted on the lower incisors of experimental rats to move their 
mandible into a forward position, to a Cl III skeletal relationship. The experimental samples 
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were able to function and chew during the experimental period with their appliance in place. 
Most of the samples’ mandible remained in a forward position (Cl III relationship) until the 
end of the experiment (Figure  3-1B), while two samples in group 3 (Day 21) had broken 
appliances at the day of sacrifice with their jaws in a Cl I relationship and the rest (around 
35%) had a Cl II relationship (Figure  4-8), because of their mandibular backward movement 
during the experiment (Table  4-6, Figure  4-9). 
 The ANOVA replaces appliance by class shows that the effect of class II and III on 
the level of PCNA and FGF8 expression were not significantly different (Bonferroni adjusted 
p = 0.61). Therefore, it was not necessary to investigate different classes further on most of 
the data. However, there were a few exceptions.  
 For PCNAgf, the mean difference between Cl I and II was significant (p=0.023), 
while it was neither significant between Cl I and III (p=1.000) nor between Cl II and III 
(p=0.110) (appendix 2, pairwise comparisons, dependent variable: PCNAgf).  
 For FGF8c, it was significant between Cl I and II (p=0.000) and between Cl II and III 
(p=0.009) but not between Cl I and Cl III (p=0.118). However, the overall statistical analysis 
shows significant changes for FGF8 during the experiment between controls and 
experimentals, considering the day and class at the same time (p=0.002) (appendix 2, tests of 
between-subjects effects, dependent variable: FGF8c, source: day*class). The significant 
difference between Cl II and III was not considered for further discussion as the current study 
was aimed at revealing the nature of the histochemical changes in response to environmental 
changes and not specifically about the differences of Cl II and III treatments. 
 For FGF8gf, it was only significant between Cl I and III (p=0.020) but not between Cl 
I and II (p=0.139) or between Cl II and III (p=1.000) (appendix 2, pairwise comparisons, 
dependent variable: FGF8gf). 
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Figure  4-8 the rat’s Mandible in a Cl II position 
The Mandible in about 35% of experimental samples was in a Cl II position on the 
day of sacrifice (Table  4-6). In these samples, lower incisors were positioned behind the 
upper incisors with extra mandibular backward movement due to the bulk of the bite-jumping 
appliance (arrow direction). The GF in Sprague Dawley rats is shallow and there is not a hard 
tissue stop at the distal of the condyle, which differs in humans (Figure 4-10). Therefore, due 
to this particular anatomic form, their condyle can easily move backward within the range of 
soft tissue limits. The ANOVA replaces appliance by class shows that Cl II and III were not 
significantly different (Bonferroni adjusted p = 0.61) with the intention of their effect on the 
level of cellular and molecular activity in the condyle and GF. 
Table  4-6 Mandibular Position in experimental samples 
        The number of the experimental rats with different Mandibular Position on the day of 
sacrifice. 
Day Class I a Class II Class III 
3 0 3 7 
14 0 4 6 
21 2 b 3 5 
30 0 2 3 
Total 2 12 21 
∗ Mandibular position in all 15 Control samples was normal; known as Cl I.  
∗ The appliance broke in 2 rats of group “Day 21” experimental samples. 
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Figure  4-9 A Diagram for Mandibular Position in experimental samples 
 The diagram shows the number of rats in each experimental group with different 
mandibular positions. The number of Cl IIIs was reduced during the experiment. This could 
be due to the special anatomy of the rats’ TMJ which allows the condyle to move backward 
as the GF is shallow (A). During function, chewing cycle and rest, it was possible that instead 
of a Cl III position, rats move their lower incisors behind the upper incisors while they wear 
the appliance (Figure  3-1). Therefore, the bulk of the appliance causes a Cl II effect and the 
anatomy of their TMJ provides room for this backward movement. However, the ANOVA 
replaces appliance by class shows that Cl II and III were not significantly different 
(Bonferroni adjusted p = 0.61) with the intention of histochemical changes in the 
experimentals’ condyle and GF.  
 
 The anatomic structure of the rat TMJ does not restrict the condylar head from 
backward movement. Therefore, some experimental rats in the current study had Cl II 
occlusion at the day of sacrifice. The anatomic structure of the rat TMJ is compared with the 
human TMJ in Figure 4-10. 
 
Table  4-7 Mandibular Position on the day of  sacrifice 
Group Class I (No.) Class II (No.) Class III (No.) 
Control *  20/20 0/20 0/20 
Experimental  2/35 12/35 21/35 
∗ Mandible was in normal Cl I position in all control samples.  
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 Figure  4-10 Schematic sagittal view of human and rat TMJ 
 The diagram shows a schematic view of a sagittal section of the human TMJ (A) and 
the rat TMJ (B); The mandibular condylar cartilaage (MCC), the articular disc (AD), the 
glenoid fossa (GF) and the articular eminence (AE) is drawn with hard lines and the outer and 
inner limits of soft tissues were approximately shown by heavy and light dashes. Regardless 
of the actual diameter there were differences in the anatomic structure of the rat TMJ in 
comparison with the human TMJ. In rats the GF is shallower, the AE is less eminent and the 
distal part of the temporal bone facing the condyle is less extended downward. Therefore, the 
rat condyle could move forward and backward within the soft tissue limits, while in the 
human condyle the movement is much more restricted. 
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Figure  4-11 mandibular position in experimental and control samples 
 For more details and diagrams on statistical analysis see appendix 2. 
4.5. Weight Gain 
 The pattern of weight gain in the experimental and control groups is shown in Figure 
 4-12. Not surprisingly, the samples’ weight increased over time and animals with the 
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appliance generally had a lower weight on sacrifice day, coupled with less weight gain during 
the experiment. The ANOVA backs this up, showing that days were significantly different 
(p<0.001) and that the appliance had a significant effect (p<0.001) on weight gain. Also, the 
change over time was significantly different in those animals with the appliance (p=0.017). 
Table  4-8 Rats' Weight on the day of Sacrifice (wts) (gr) 
The Dependent Variable was rats’ Weight at Sacrifice (wts)/day-class, and was compared 
within experimentals vs. controls. 
    95% Confidence Interval 
Day Group Class Mean Std. Error Lower Bound Upper Bound 
3 Control Cl I 110.09a 4.905 100.164 120.023 
 
Experimental 
Cl II 96.48a 6.180 83.971 108.993 
 Cl III 99.90a 4.246 91.301 108.492 
14 Control Cl I 154.72a 5.385 143.816 165.620 
 
Experimental 
Cl II 148.76a 5.291 138.050 159.472 
 Cl III 148.80a 4.528 139.631 157.964 
21 Control Cl I 176.06a 5.319 165.289 186.824 
 
Experimental 
Cl II 167.64a 6.111 155.270 180.011 
 Cl III 156.69a 4.883 146.809 166.579 
30 Control Cl I 205.93a 4.733 196.347 215.509 
 
Experimental 
Cl II 179.14a 7.522 163.914 194.371 
 Cl III 165.86a 6.158 153.390 178.323 
a. Covariates appearing in the model were evaluated at the following values: Weight at four 
weeks of age (wt4) = 91.489. 
b. Weight gain was not significantly different between Cl II and Cl III experimentals; 
p=0.614.  
c. Between controls and experimentals the difference was significant; p=0.005 for Cl I and 
II, p=0.000 for Cl I and III. 
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Figure  4-12 the diagram for rats' Weight at Sacrifice (wts) (gr) 
The pattern of weight gain in the experimentals and controls was similar. However, 
the bite-jumping appliance significantly affected the weight gain process by reducing the 
level of weight gain (p=0.005 for Cl II and p= 0.000 for Cl III). This could be due to 
functional restrictions during eating in experimental samples, with regard to the bulk and 
position of the bite-jumping appliance. Cl III experimental weight gain was lesser than Cl II 
samples, but it was not statistically significant (p=0.614). 
  For more details and diagrams on statistical analysis see appendix 2, section weight. 
 
 
 
 
 
 
95 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION and CONCLUSION  
 
 
 
 
 
 
96 
 
5. Discussion 
 The histological structures of the rats’ TMJ are similar to that of humans, with some 
differences in morphology (19, 222). Due to this similarity and the possibility of a 
histochemical study on rats, based on previous studies (108, 109), fifty-five Sprague Dawley 
rats were used in this experiment, as used in other histological and biochemical investigations 
(6-9, 12, 19, 23, 28, 109, 123, 126, 130, 131, 133, 148, 223-231).   
 The rats continuously gain weight during their life. It is mentioned by Shen et al 2006 
that the maximum rate of rats’ growth is between 5 to 9 weeks of their age and resembles the 
adolescent growth spurt in humans (8). The accurate growth curve for the human condyle by 
approaches of gross measurement, such as cephalometric analysis, is difficult to obtain. In 
this situation it is of particular significance to investigate the temporal pattern of the condylar 
growth through biochemical studies in a rat experimental model, which could help to infer 
upon that of a human (109, 232)  
5.1. Functional Mandibular Advancement 
 This experiment, based on previous similar studies, is performed to clarify the 
mechanism of condylar and GF adaptation in response to the mandibular advancement (2, 10, 
15, 20). In growing patients with retrusive mandibles, growth modification of the mandible is 
the main goal of orthodontic treatments and most of these remodeling activities occur in the 
TMJ area, which is the target of several studies in this field (2, 6-8, 10, 19, 61, 233).  
 Even though some studies on monkeys indicate that such adaptive responses are non-
existent, and negligible (63, 124, 234, 235), several other findings indicate positive 
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significant TMJ adaptation in response to mandibular advancement (6, 7, 23, 64, 118, 128, 
129, 132, 236). 
 The bite-jumping appliance in this study is used to move the mandible to a forward 
position while slightly opening the bite. This functional appliance will activate different parts 
of the TMJ (13, 62, 128, 237). The effect of the bite-jumping appliance is affected by 
different factors, such as the duration of the treatment, the rate of the mandibular growth, the 
direction and the magnitude of the force (17, 57, 62, 67-69). These factors, which affect the 
results of the study, were kept as consistent as possible for all samples. 
 The translation of the condyle toward the articular eminence with a posterior-inferior 
rotation of the entire mandible causes space reduction in superior joint spaces in the condyle 
whilst posterior joint space increases. This function applies stretching forces to the distal and 
distal-superior part of the condyle and the areas of the GF facing these areas of the condyle. 
On the other site, compressive forces are applied on the anterior and anterior-superior parts of 
the condyle and their transactional sites on the GF (8, 19, 61, 131, 238).  
 A Cl II functional correction occurs through different structural mechanisms by 
affecting maxillary and mandibular structures, such as TMJ remodeling and encouragement 
of mandibular growth, retardation or redirection of the maxillary growth in the mesial or 
vertical direction, and furthermore by inducing dentoalveolar changes in the maxillary and 
the mandibular anterior segment (55). The current study is to evaluate the nature of 
histochemical changes occurring in the MCC and the GF. The results of these changes are 
TMJ remodeling and mandibular growth modification.  The Mandible is ultimately replaced 
to a more forward position. 
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5.2. TMJ Bone Remodeling & Growth Modification 
 Structural bases of the stomatognathic system are the maxillary and the mandibular 
skeletal structures. The boney parts of the TMJ are the condyle of the mandible and the GF of 
the temporal bone.  
 The MCC is the most posterior-superior part of the mandible and the mandibular GF 
is part of the temporal bone. The temporal bone in the rat consists of the squamosal, petrosal, 
tympanic, and mastoid bones. The only relevant part to the joint is the squamosal bone, which 
is a shallow bowl-like bone. The retrotympanic and the zygomatic are two strong processes 
of the squamosal bone. The mandibular GF is located ventral to the base of the zygomatic 
process, narrow and sagittally oriented. This fossa in the rat’s TMJ is shallow with an 
anteroposterior long axis. It has a lateral flange and no posterior or anterior flanges and the 
articular eminence is much less distinct in comparison with the human’s articular eminence 
(reported by Rabie et al 2001(12)). 
  The posterior, middle, and anterior parts of the GF are compared by Rabie et al 2001 
during mandibular advancement. A substantial increase in bone formation in all of these three 
main regions of the GF on mandibular protrusion is shown when compared with untreated 
matched control rats. The highest level of bone formation was recorded in the posterior 
regions (12). 
 The aim of this study was evaluating the patterns of hypertrophic and proliferative 
activities in the posterior-superior part of the MCC and the posterior part of the GF during 
their adaptive remodeling response to the mandibular protrusion.  
 The evidence confirms that the MCC and the GF have the capability of functional 
adaptation in response to the environmental changes and responsive to mechanical 
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stimulation. This is consistent with many other investigations (71, 72, 76-78). The pattern of 
this adaptive response is different in the MCC and the GF, but the MCC and the GF growth 
modification are in harmony with each other.  
 This harmony could be described by the growth relativity hypothesis and the 
functional matrix theory. The mandible is displaced to a forward position, viscoelastic forces 
are applied on the MCC-GF complex at the same time in reverse directions, and the forces 
are transduced by being radiated beneath the articular layers of both the MCC and the GF 
(see pages 23-25) (80-85). This force transduction results in an overall significant difference 
between the experimental and control animals on cellular and molecular activities in the 
MCC and the GF during the experiment. 
 The role of the MCC in the process of the TMJ’s growth and development and its 
adaptive response to mandibular advancement is remarkably higher, particularly during the 
period of the present study. The rate of cellular proliferative and hypertrophic activities and 
morphological changes in the GF is much lower than in the MCC, even at the 3rd day of the 
experiment. This level of activity drops down towards the end of the study, to the extent that 
in a few samples no PCNA or FGF8 expression is detected in the GF. It could be inferred 
from this finding that during the 27-54 days of rats’ age, only a little amount of bone 
formation and adaptive remodeling occurs in the GF.  
 During mandibular forward positioning, the TMJ adaptation occurs mostly in the 
MCC and less in the GF, because the level of cellular and molecular activity in the GF is 
remarkably lower than in the MCC. The level of cellular and molecular activities during the 
current study showed a significant decrease in the GF after the 3rd day of the experiment.  
 This lower amount of activity in the GF might show that the whole TMJ’s adaptation 
occurs mainly by ossification and relocation of the MCC and relocation of the GF, as a 
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harmonised biologic response to mandibular protrusion. Otherwise, it is possible that the GF 
is not significantly relocated from its initial position, which could be a reason for future 
relapses of a successful functional mandibular treatment. If the GF does not remarkably 
remodel or relocate, then the soft tissue attachments pull the condyle back to its initial 
relationship with the GF. For clearer and more detailed information in this regard, these 
possibilities should be precisely studied and evaluated by a combination of histochemical, 
cephalometric and electromyographic methods for a longer period of time.  
 Signaling molecules of the FGF and Tgfβ families regulate the endochondral 
ossification at several levels (89), therefore the results of the current study might be 
consistent with the fact that the mandibular condyle is a growth site and is ossified through 
endochondral ossification (71) (see pages 26-29).  
 However, endochondral ossification in the GF is only observed during the initial 
stages of rats’ growth (27 days of rats age), indicated by detecting FGF8 at that age and not 
after that. This might indicate that osteogenesis generally slows down in the rats’ GF at this 
age, or that the intramembranous ossification is the dominant ossification process in the GF 
afterward and there is no cartilage tissue in the GF during later growth and development. 
Intramembranous ossification in the GF is similarly reported in other studies (74).  
 The evidence and results suggest the endochondral ossification in the MCC and more 
likely intramembranous ossification in the GF take place during normal growth, development 
and adaptive remodeling in response to functional therapy.  
 On the whole, FGF8 and PCNA findings indicates that extra bone formation in 
response to mandibular forward positioning is due to extra molecular activity and cellular 
morphologic differentiations, and not due to extra cellular proliferation.    
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5.3. Histological Features 
The chondrocytes in the early hypertrophic zone have proliferative activity in the late 
embryonic stage (98) and the first sign of cartilage calcification is present in this zone (17). 
Immunopositive cells for FGF8 molecules are detected in the cytoplasm of the chondrogenic 
cells in the early hypertrophic and hypertrophic zones, which is consistent with earlier 
research (42, 89).  
The cells in the proliferative layer are in their active dividing mitotic stage and PCNA 
molecules are mainly localized in this layer, which is similarly observed by other observers 
(43-45, 47). However, some cells are positively stained for PCNA in more superficial and 
dipper layers as well. This could indicate that cells in the other layers have a dividing 
capability but a lesser amount of activity, in both the MCC and the GF (see pages 75-80).     
5.3.1. Cellular changes in the Mandibular Condylar 
Cartilage 
 Even though in this study particular methods are not applied for a clear distinction 
between different cellular layers in the MCC, the six different layers could be determined in 
the MCC—as reported by other researchers—as five distinctive cellular zones plus the bone 
area (17, 19, 22, 89) (see pages 32, 70).  
 It is reported that longitudinal bone growth during endochondral bone formation 
depends on chondrogenesis and the increase in the cartilage matrix is closely correlated to the 
bone formation in response to mandibular advancement (6, 8, 125). Mesenchymal cells in the 
articular layer and the proliferative zone are re-oriented by physical stretching of the posterior 
fibers of the disc which might trigger the enhanced differentiation and maturation of the 
chondrocytes in the hypertrophic layer. This could indicate more chondrogenesis and 
therefore more endochondral ossification (126).  
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 The results show that in the MCC the hypertrophic activities significantly increased 
while the proliferative activity did not differ significantly between the experimental samples 
and the controls. This indicates that thickening of the posterior part of the condyle as an 
adaptive response to the condyle’s forward positioning (122) is due to cellular morphologic 
changes and not due to an increase in the number of cells. Other methods of investigation are 
required for individually counting the cells distinctively and accurately in different layers and 
comparing the layers with each other. 
5.3.2. Cellular changes in the GF 
 The cellular features in the GF are similar to those in the Rabie et al 2001 study (12); 
however there is no particular method for pure cellular investigation in the present study. The 
fibroblasts in the superficial fibrous layer were observed as round cells during the first stage 
of the experiment in the 27 day-old rats. Subsequently, they were stretched, flattened and 
more oriented towards the direction of the mandibular forward positioning (see pages 38-43, 
70 Figure 4-1).  
 The cellular layers are narrower in the GF and barely distinguishable in comparison 
with the MCC, and  some layers are also different from the MCC (239) (Figure 4-1). Only six 
different layers are observed in 27 day-old rats and in older samples beneath the layer of 
proliferation, hypertrophic cells and chondrocytes do not exist and connective tissue and 
osteoblasts with different morphology replace the proliferative zone and the erosive zone. 
This could indicate the nature of intramembranous ossification in the GF, which is also 
reported by Wright et al 1974 (74). 
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5.4. Molecular Changes 
Several growth factors regulate the chondrogenesis process which is regarded as the 
initial stage of condyle and GF remodeling, such as Sox9 (6), PTHrP (106), Cbfa1 (108), type 
X collagen (230) type II collagen (6, 7, 19), VEGF(140, 240), IGF I and II (22), FGF  (17, 
42).  
The higher amount of FGF8 and PCNA expression in experimental samples, in 
comparison with control samples, generally shows an enhanced osteogenic transition 
occurring in both the MCC and the GF, with the exception of FGF8c and PCNAgf on 
experiment day 30, during which the level of expression in the control animals was slightly, 
though not significantly, higher than in the experimentals. Further long-term studies are 
required to find out the reason for the lower molecular and cellular activities in the MCC and 
the GF. 
5.4.1. FGF8 
The results show that FGF8 expression is significantly affected by mandibular 
advancement. This indicates that the change in biophysical environment of the TMJ leads to 
the MCC-GF adaptation and enhances molecular activity in both the MCC and the GF (7, 19, 
239, 241).  
The zone of FGF8 expression is mainly located within the deep columnar proliferative 
layer and early hypertrophic layer. By considering the level of PCNA expression as an 
indicator for proliferative activity (42, 43), which did not significantly increase in this study 
in the experimental samples, the zone of FGF8 expression indicates that FGF8 is more 
involved in hypertrophic activities than in chondrocytes proliferation. FGF8  plays a role in 
cellular chondrogenic differentiation and creating morphologic changes from  mesenchymal 
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cells to chondroblasts and chondroblasts to bone-making cells. This is also reported by 
Minina et al: on the molecular level, FGF signaling reduces chondrocyte proliferation and 
induces hypertrophic differentiation of chondrocytes (162). 
 Evaluating the expression of FGF8 in experimentals versus controls suggests that 
mandibular advancement does not change the pattern of molecular activity but just increases 
the level of activity. The pattern of FGF8 expression follows the pattern of the TMJ’s normal 
growth and development, in reference to the controls, which reached the maximum level of 
expression on the 38th day of the rats’ age in the MCC (23) and on the 27th day in the GF 
(Figure 4-4). This indicates endochondral ossification in the MCC and non-chondrogenic 
ossification in the GF (130).   
 The role of FGF8 in regulating the cartilage formation in the skull (193) and its 
involvement in cartilage and bone formation (194) and stimulating the chondrocytes 
(evidenced in the avian) (195)  is considered in the current study. This is important because 
FGF8 is reported as a precise control key of localization and patterning of cartilage and 
endochondral bone elements in the head (42, 169, 198) (see pages 48-53). 
 The FGF8 pick of expression is approximately at the same level in experimentals and 
controls. Considering this evidence, and the fact that FGF8c is slightly higher in controls on 
Day 30, it is possible that stepwise advancement may generate more changes in the MCC-GF 
complex than one-step advancement. This is similarly suggested by other researchers (23, 
130). 
5.4.2. PCNA 
 PCNA is a marker for cell proliferation; thus, detecting PCNA in cells indicates 
proliferative activity (44-47, 198, 214-220). The zone of PCNA expression in the current 
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study is clearly immunolocalized in the proliferative layer, which is consistent with other 
reports on PCNA (43, 47) (see pages 53-55). 
 It is reported that the growth potential of the MCC and the GF is influenced by the 
number of replicating mesenchymal cells and this replication is increased by functional 
orthopedics, such as the effect of bite-jumping appliances on the the MCC in young rats (22, 
148).  
However, the results in the current experiment do not show a significant difference 
between PCNA expression in the MCC and the GF of experimentals and controls. This 
finding indicates that more bone formation during the MCC-GF complex adaptation is not 
due to more cellular proliferation. By considering this, along with the level of FGF8 
expression, it can be inferred that more bone formation occurs as a result of more cellular 
activity, because FGF8 could be known as an indicator for cellular morphologic changes and 
hypertrophic activities (42, 158, 162). 
Even though overall results note no significant difference in PCNA-values between 
the control and the experimental groups, the level of PCNA expression in the experimentals 
is higher than in the controls, while in the GF it is still remarkably lower than the MCC in 
both controls and experimentals (Table  4-4, Figure  4-6). This suggests that most of the 
growth, developmental procedures and adaptive responses which finally result in mandibular 
growth, are taking place in the condyle and much less in the GF (Table  4-2Table  4-4, Figure 
 4-3Figure  4-6). 
5.5. Mandibular position 
 The bite-jumping appliance was designed to reposition the rats’ mandible to a more 
forward position in a Cl III relationship with the maxilla. But, twelve experimental rats out of 
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thirty experimentals end up in a Cl II position. This is due to the anatomic structure of the 
rats’ TMJ and its surrounding soft tissues, which make the condyle capable of functionally 
moving backward (see pages 80-84).  
 Overall, based on the statistical analysis, the TMJ’s histochemical differences 
between Cl II and III animals related to the level of PCNA and FGF8 expression are non-
significant (Bonferroni adjusted p = 0.61). However, there are few exceptions. Additionally, 
this study aims to investigate the nature of the TMJ’s biologic response to the environmental 
changes. Therefore, the mandibular Cl II and Cl III positions are not separately evaluated and 
discussed. For detailed statistical analysis see appendix 2. 
5.6. Weight gaining 
 The bulk of the bite-jumping appliance and its interference with the rats’ normal 
chewing function could be the reason for less weight gain in the experimental samples. The 
effect of weight as a covariate on all dependent variables of the study is non-significant; 
FGF8c (p=0.431), FGF8gf (p=0.782), PCNAc (p=0.817) and PCNAgf (p=0.439). 
6. Conclusion 
1. The results of this study indicate that structural and molecular adaptations occurred in 
the MCC and the GF of the experimental animals; 
 The results of this study indicate that structural and molecular adaptations occurred in 
the MCC and the GF of the experimental animals. Increased proliferation was noted in the 
MCC and the GF, but not significantly. However, hypertrophic differentiations were 
significantly increased in both parts, which could cause more bone formation during the 
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adaptive response. Therefore, mandibular growth modification takes place as an end result of 
extra cellular morphologic differentiations and hypertrophic changes in the TMJ. 
2. Mandibular growth modification takes place as an end result of cellular morphologic 
differentiation and hypertrophic changes in both the MCC and the GF; 
3. Endochondral bone formation is involved in the MCC’s bone formation and more 
intramembranous ossification in the GF; 
 The level and the pattern of FGF8 expression suggests that bone formation and 
remodeling in the MCC is mainly achieved through an endochondral ossification process, 
while endochondral ossification in the GF might not be the prominent procedure in the GF’s 
growth, development and adaptive response. Therefore, more intramembranous ossification is 
involved in the GF. 
4. The relapse of Cl II functional treatment might be due to remarkably lesser adaptation 
in the GF in comparison with the MCC. 
Future direction 
The future direction would be to design and perform studies covering  longer periods of 
the rats’ lives and comparing the condyle and the GF with other growth centres and growth 
sites on each sample; such as Epiphyseal plates, Synchondrosis (e.g. Spheno-occipital 
Synchondrosis), Maxillary sutures (e.g. Intermaxillary suture), Cranial sutures and  
Mandibular Symphyses at earlier stages of  growth. This could be completed with 
cephalometric evaluations during the period of the experiment to measure the level and 
directions of growth and development beside the histochemical evaluations.  
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 This wide range of evaluations and comparison within different structures could be 
helpful for better investigations on the correlations and possible interactions between 
different tissues during natural growth and development, and under the effect of different 
orthodontic appliances.  
 This information is essential for better diagnoses and treatment plans for orthodontic 
problems, since orthodontics, and particularly orthopedic treatments deal with growth 
modifications, redirections or retardations through histochemical changes. Therefore, better 
understanding of the relevant mechanisms at the level of histochemistry will guide 
practitioners to better approaches on the clinical level.  
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Appendices: 
Appendix 1: Electro-microscopic images of 
Immunostained TMJ sections 
Slides are randomly collected, and different magnifications in each column of each 
table are related to the same section. 
FGF8c 
• Electro-microscope images from immunohistochemicaly stained sections for 
Fibroblast Growth Factor 8 in the mandibular condylar cartilage  
 
Group 1; Day 3; 27-day old rats 
Condyle 
Magnification FGF8 Control FGF8 Experimental 
 
 
 
 
 
 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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Group 2; Day 14; 35-day old rats 
Condyle 
Magnification FGF8 Control FGF8 Experimental 
 
 
 
 
 
 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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Group 3; Day 21; 45-day old rats 
Condyle 
Magnification FGF8 Control FGF8 Experimental 
 
 
 
 
 
 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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Group 4;  Day 30; 53-day old rats 
Condyle 
Magnification FGF8 CONTROL FGF8 Experimental 
 
 
 
 
 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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FGF8gf 
• Electro-microscope images from immunohistochemicaly stained sections for 
Fibroblast Growth Factor 8 in the glenoid fossa: 
 
Group 1;  Day 3; 27-day old rats 
Glenoid Fossa 
Magnification FGF8 Control FGF8 Experimental 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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Group 2;  Day 14; 38-day old rats 
Glenoid Fossa 
Magnification FGF8 Control FGF8 Experimental 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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Group 3;  Day 21; 45-day old rats 
Glenoid Fossa 
Magnification FGF8 Control FGF8 Experimental 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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Group 4;  Day 30; 53-day old rats 
Glenoid Fossa
Magnification FGF8 Control FGF8 Experimental 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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PCNAc 6 
• Electro-microscope images from immunohistochemicaly stained sections for 
Proliferating Cell Nuclear Antigen in the mandibular condylar cartilage. 
 
 
Group 1;  Day 3; 27-day old rats 
Condyle
Magnification PCNA Control PCNA Experimental 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
6 More details about PCNAgf are available in Dr. Zoe Potres’s MPhil thesis on same 
project at the Department of Orthodontics, School of Dentistry, The University of 
Sydney, NSW- Australia 2009. 
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Group 2;  Day 14; 38-day old rats 
Condyle
Magnification PCNA Control PCNA Experimental 
 
 
 
 
 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
60X 
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Group 3;  Day 21; 45-day old rats 
Condyle
Magnification PCNA Control PCNA Experimental 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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Group 4;  Day 30; 53-day old rats 
Condyle
Magnification PCNA Control PCNA Experimental 
10X 
 
 
 
 
 
 
 
 
 
20X 
 
 
 
 
 
 
 
 
 
 
60X 
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PCNAgf 
• Electro-microscope images from immunohistochemicaly stained sections for 
Proliferating Cell Nuclear Antigen in the glenoid fossa. 
 
Group 1;  Day 3; 27-day old rats 
Glenoid Fossa 
Magnification PCNA Control PCNA Experimental 
20X 
 
 
 
 
 
 
 
Group 2;  Day 14; 38-day old rats 
Glenoid Fossa
Magnification PCNA Control PCNA Experimental 
 
 
20X 
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Group 3;  Day 21; 45-day old rats 
Glenoid Fossa
Magnification PCNA Control PCNA Experimental 
20X 
 
 
 
 
 
 
 
 
 
 
Group 4;  Day 30; 53-day old rats 
Glenoid Fossa
Magnification PCNA Control PCNA Experimental 
20X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2:  Statistical Analysis (SPSS output) 
FGF8c 
• Expression of Fibroblast Growth Factor 8 in the mandibular condylar cartilage: 
Graph 
 
Notes
Output Created 2008-11-24T14:27:43.500 
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data 
File 55 
Syntax GRAPH 
/SCATTERPLOT(BIVAR)=days WITH 
FGF8c BY class 
/MISSING=LISTWISE. 
 
Resources Processor Time 0:00:00.328 
Elapsed Time 0:00:00.219 
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Univariate Analysis of Variance 
 
Notes (class-days) 
Output Created 2008-11-24T14:34:41.578
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA FGF8c BY days class WITH wts 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(days) WITH(wts=MEAN) 
COMPARE ADJ(BONFERRONI) 
  /EMMEANS=TABLES(class) WITH(wts=MEAN) 
COMPARE ADJ(BONFERRONI) 
  /EMMEANS=TABLES(class*days) WITH(wts=MEAN) 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=days class class*days wts. 
 
Resources Processor Time 0:00:00.031
Elapsed Time 0:00:00.016
[$DataSet] D:\Documents and Settings\ppetocz\My Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Notes (appliance-days) 
Output Created 2008-11-24T14:43:28.313 
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55 
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA FGF8c BY days appl WITH wts 
/METHOD=SSTYPE(3) 
/INTERCEPT=INCLUDE 
/EMMEANS=TABLES(days) WITH(wts=MEAN) 
/EMMEANS=TABLES(appl) WITH(wts=MEAN) 
/EMMEANS=TABLES(appl*days) WITH(wts=MEAN) 
/CRITERIA=ALPHA(.05) 
/DESIGN=days appl appl*days wts. 
 
Resources Processor Time 0:00:00.000 
Elapsed Time 0:00:00.000 
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
128 
 
Between-Subjects Factors (class-days)
  N 
Days 3 14 
14 14 
21 13 
30 9 
Class 0 17 
2 12 
3 21 
 
Tests of Between-Subjects Effects (class-days) 
Dependent Variable:FGF8c     
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 21056.756a 12 1754.730 116.411 .000
Intercept 460.206 1 460.206 30.531 .000
Days 15945.871 3 5315.290 352.622 .000
Class 369.622 2 184.811 12.261 .000
days * class 405.643 6 67.607 4.485 .002
Wts 9.555 1 9.555 .634 .431
Error 557.724 37 15.074   
Total 112012.000 50    
Corrected Total 21614.480 49    
a. R Squared = .974 (Adjusted R Squared = .966)   
 
 0Between-Subjects Factors (appliance-days)
  N 
days 3 14 
14 14 
21 15 
30 9 
appl 0 17 
1 35 
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Tests of Between-Subjects Effects (appliance-days) 
Dependent Variable:FGF8c     
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 20870.182a 8 2608.773 118.190 .000 
Intercept 352.940 1 352.940 15.990 .000 
days 13901.216 3 4633.739 209.931 .000 
appl 236.500 1 236.500 10.715 .002 
days * appl 205.175 3 68.392 3.098 .037 
wts .324 1 .324 .015 .904 
Error 949.126 43 22.073   
Total 117452.000 52    
Corrected Total 21819.308 51    
a. R Squared = .957 (Adjusted R Squared = .948)   
 
Estimated Marginal Means 
 
1. Days 
 
Estimates
Dependent Variable:FGF8c   
Days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
3 18.402a 2.968 12.389 24.415 
14 69.271a 1.100 67.042 71.500 
21 51.329a 1.569 48.150 54.508
30 27.176a 2.499 22.113 32.238 
a. Covariates appearing in the model are evaluated at the following values: wts = 147.660. 
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Pairwise Comparisons
Dependent Variable:FGF8c     
(I) days (J) days 
Mean Difference
(I-J) Std. Error Sig.a
95% Confidence Interval for Differencea 
Lower Bound Upper Bound 
3 14 -50.869* 3.421 .000 -60.404 -41.334 
21 -32.927* 4.170 .000 -44.551 -21.303 
30 -8.774 5.162 .585 -23.163 5.616 
14 3 50.869* 3.421 .000 41.334 60.404 
21 17.942* 1.730 .000 13.120 22.765 
30 42.095* 2.483 .000 35.173 49.018 
21 3 32.927* 4.170 .000 21.303 44.551 
14 -17.942* 1.730 .000 -22.765 -13.120 
30 24.153* 2.008 .000 18.557 29.750 
30 3 8.774 5.162 .585 -5.616 23.163 
14 -42.095* 2.483 .000 -49.018 -35.173 
21 -24.153* 2.008 .000 -29.750 -18.557 
Based on estimated marginal means    
*. The mean difference is significant at the .05 level 
a. Adjustment for multiple comparisons: Bonferroni. 
 
Univariate Tests
Dependent Variable:FGF8c    
 Sum of Squares df Mean Square F Sig. 
Contrast 15945.871 3 5315.290 352.622 .000 
Error 557.724 37 15.074   
The F tests the effect of days. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
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2. Class 
 
Estimates 
Dependent Variable:FGF8c   
class Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 37.643a 1.234 35.143 40.144 
2 45.833a 1.155 43.492 48.173 
3 41.157a .917 39.298 43.015 
a. Covariates appearing in the model are evaluated at the following values: wts = 147.660. 
 
Pairwise Comparisons
Dependent Variable:FGF8c     
(I) class (J) class 
Mean Difference 
(I-J) Std. Error Sig.a
95% Confidence Interval for Differencea
Lower Bound Upper Bound 
0 2 -8.189* 1.691 .000 -12.429 -3.949 
3 -3.513 1.646 .118 -7.640 .613 
2 0 8.189* 1.691 .000 3.949 12.429 
3 4.676* 1.475 .009 .977 8.375 
3 0 3.513 1.646 .118 -.613 7.640 
2 -4.676* 1.475 .009 -8.375 -.977 
Based on estimated marginal means    
*. The mean difference is significant at the .05 level.   
a. Adjustment for multiple comparisons: Bonferroni.  
 
Univariate Tests
Dependent Variable:FGF8c    
 Sum of Squares df Mean Square F Sig. 
Contrast 369.622 2 184.811 12.261 .000 
Error 557.724 37 15.074   
The F tests the effect of class. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
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3. Class * days 
 
Dependent Variable:FGF8c   
class days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3 14.720a 2.961 8.721 20.719 
14 61.761a 2.044 57.618 65.903 
21 45.022a 2.317 40.327 49.717 
30 29.071a 3.768 21.437 36.705 
2 3 21.545a 3.812 13.821 29.269 
14 74.027a 1.942 70.093 77.961 
21 61.224a 2.505 56.148 66.299 
30 26.535a 3.355 19.738 33.332 
3 3 18.940a 3.291 12.272 25.609 
14 72.025a 1.603 68.777 75.274 
21 47.740a 1.864 43.963 51.518 
30 25.921a 2.522 20.810 31.032 
a. Covariates appearing in the model are evaluated at the following values: wts = 147.660. 
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4. Appl 
 
Dependent Variable:FGF8c   
appl Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 37.121a 1.451 34.194 40.047 
1 42.952a .852 41.233 44.671 
a. Covariates appearing in the model are evaluated at the following values: wts = 148.077. 
 
5. Appl * days 
Dependent Variable:FGF8c   
appl days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3 16.182a 3.521 9.081 23.283 
14 61.337a 2.456 56.384 66.290 
21 44.012a 2.737 38.494 49.531 
30 26.951a 4.400 18.078 35.823 
1 3 21.676a 3.798 14.017 29.336 
14 72.719a 1.494 69.706 75.732 
21 52.209a 1.738 48.705 55.713 
30 25.203a 2.686 19.786 30.619 
a. Covariates appearing in the model are evaluated at the following values: wts = 148.077. 
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FGF8gf 
• Expression of Fibroblast Growth Factor 8 in the glenoid fossa: 
 
Graph 
 
Notes
Output Created 2008-11-24T14:28:06.969 
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data File 55 
Syntax GRAPH 
/SCATTERPLOT(BIVAR)=days WITH FGF8gf BY class 
/MISSING=LISTWISE. 
 
Resources Processor Time 0:00:00.344 
Elapsed Time 0:00:00.234 
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Univariate Analysis of Variance 
 
Notes (class-days) 
Output Created 2008-11-24T14:35:24.219 
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55 
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA FGF8gf BY days class WITH wts 
/METHOD=SSTYPE(3) 
/INTERCEPT=INCLUDE 
/EMMEANS=TABLES(days) WITH(wts=MEAN) 
COMPARE ADJ(BONFERRONI) 
/EMMEANS=TABLES(class) WITH(wts=MEAN) 
COMPARE ADJ(BONFERRONI) 
/EMMEANS=TABLES(class*days) WITH(wts=MEAN) 
/CRITERIA=ALPHA(.05) 
/DESIGN=days class class*days wts. 
 
Resources Processor Time 0:00:00.031 
Elapsed Time 0:00:00.015 
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Notes (appliance-days) 
Output Created 2008-11-24T14:43:45.063 
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55 
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA FGF8gf BY days appl WITH wts 
/METHOD=SSTYPE(3) 
/INTERCEPT=INCLUDE 
/EMMEANS=TABLES(days) WITH(wts=MEAN) 
/EMMEANS=TABLES(appl) WITH(wts=MEAN) 
/EMMEANS=TABLES(appl*days) WITH(wts=MEAN) 
/CRITERIA=ALPHA(.05) 
/DESIGN=days appl appl*days wts. 
 
Resources Processor Time 0:00:00.031 
Elapsed Time 0:00:00.015 
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Between-Subjects Factors (class-days)
  N 
days 3 14 
14 15 
21 11 
30 9 
class 0 18 
2 12 
3 19 
 
Tests of Between-Subjects Effects (class-days) 
Dependent Variable:FGF8gf     
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 2155.694a 12 179.641 46.526 .000 
Intercept 6.387 1 6.387 1.654 .207 
days 260.586 3 86.862 22.497 .000 
class 32.819 2 16.409 4.250 .022 
days * class 90.509 6 15.085 3.907 .004 
wts .300 1 .300 .078 .782 
Error 139.000 36 3.861   
Total 3601.000 49    
Corrected Total 2294.694 48    
a. R Squared = .939 (Adjusted R Squared = .919)   
 
 
 
 
 
 
 
 
 
 
 
Between-Subjects Factors (appliance-days)
  N 
days 3 14 
14 15 
21 13 
30 9 
appl 0 18 
1 33 
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Tests of Between-Subjects Effects (appliance-days) 
Dependent Variable:FGF8gf     
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 2184.363a 8 273.045 75.142 .000 
Intercept 3.899 1 3.899 1.073 .306 
days 279.925 3 93.308 25.678 .000 
appl 37.768 1 37.768 10.394 .002 
wts .005 1 .005 .001 .970 
days * appl 83.884 3 27.961 7.695 .000
Error 152.617 42 3.634   
Total 3602.000 51    
Corrected Total 2336.980 50    
a. R Squared = .935 (Adjusted R Squared = .922)   
 
 
Estimated Marginal Means 
 
1. days 
 
Estimates
Dependent Variable:FGF8gf   
Days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
3 14.655a 1.501 11.610 17.700 
14 2.263a .535 1.178 3.348 
21 .471a .842 -1.236 2.177 
30 .774a 1.281 -1.823 3.372 
a. Covariates appearing in the model are evaluated at the following values: wts = 147.388. 
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Pairwise Comparisons
Dependent Variable:FGF8gf     
(I) days (J) days 
Mean Difference  
(I-J) 
Std. 
Error Sig.a 
95% Confidence Interval for Differencea
Lower Bound Upper Bound 
3 14 12.392* 1.718 .000 7.595 17.188 
21 14.184* 2.149 .000 8.185 20.184 
30 13.881* 2.632 .000 6.533 21.228 
14 3 -12.392* 1.718 .000 -17.188 -7.595 
21 1.793 .906 .333 -.736 4.321 
30 1.489 1.268 1.000 -2.051 5.029 
21 3 -14.184* 2.149 .000 -20.184 -8.185 
14 -1.793 .906 .333 -4.321 .736 
30 -.304 1.032 1.000 -3.184 2.577 
30 3 -13.881* 2.632 .000 -21.228 -6.533 
14 -1.489 1.268 1.000 -5.029 2.051 
21 .304 1.032 1.000 -2.577 3.184 
Based on estimated marginal means    
*. The mean difference is significant at the .05 level.  
a. Adjustment for multiple comparisons: Bonferroni.  
 
Univariate Tests
Dependent Variable:FGF8gf    
 Sum of Squares df Mean Square F Sig. 
Contrast 260.586 3 86.862 22.497 .000 
Error 139.000 36 3.861   
The F tests the effect of days. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
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2. class 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimates 
Dependent Variable:FGF8gf   
class Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3.184a .608 1.950 4.418 
2 4.919a .585 3.733 6.105 
3 5.520a .477 4.552 6.487 
a. Covariates appearing in the model are evaluated at the following values: wts = 147.388. 
Pairwise Comparisons
Dependent Variable:FGF8gf     
(I) class (J) class 
Mean Difference 
(I-J) Std. Error Sig.a
95% Confidence Interval for Differencea
Lower Bound Upper Bound 
0 2 -1.735 .840 .139 -3.845 .375 
3 -2.336* .812 .020 -4.375 -.296 
2 0 1.735 .840 .139 -.375 3.845 
3 -.601 .755 1.000 -2.498 1.296 
3 0 2.336* .812 .020 .296 4.375 
2 .601 .755 1.000 -1.296 2.498 
Based on estimated marginal means    
a. Adjustment for multiple comparisons: Bonferroni.  
*. The mean difference is significant at the .05 level.  
Univariate Tests 
Dependent Variable:FGF8gf    
 Sum of Squares Df Mean Square F Sig. 
Contrast 32.819 2 16.409 4.250 .022 
Error 139.000 36 3.861   
The F tests the effect of class. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
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3. class * days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dependent Variable:FGF8gf   
class days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3 10.469a 1.478 7.471 13.466 
14 1.079a .924 -.794 2.952 
21 .475a 1.273 -2.106 3.057 
30 .712a 1.928 -3.199 4.623 
2 3 15.563a 1.936 11.636 19.489 
14 2.507a .983 .514 4.500 
21 .828a 1.274 -1.756 3.412 
30 .777a 1.708 -2.688 4.242 
3 3 17.933a 1.645 14.598 21.269 
14 3.203a .813 1.555 4.852 
21 .108a 1.056 -2.034 2.250 
30 .834a 1.283 -1.769 3.436 
a. Covariates appearing in the model are evaluated at the following values: wts = 147.388. 
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4. appl 
 
Dependent Variable:FGF8gf   
appl Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3.088a .573 1.933 4.244 
1 5.345a .349 4.641 6.050 
a. Covariates appearing in the model are evaluated at the following values: wts = 147.824. 
 
5. appl * days 
 
Dependent Variable:FGF8gf   
appl days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3 10.758a 1.405 7.923 13.592 
14 1.010a .889 -.785 2.804 
21 .278a 1.207 -2.157 2.713 
30 .308a 1.803 -3.330 3.945 
1 3 17.503a 1.526 14.424 20.583 
14 2.903a .607 1.678 4.128 
21 .348a .749 -1.162 1.859 
30 .626a 1.098 -1.590 2.842 
a. Covariates appearing in the model are evaluated at the following values: wts = 147.824. 
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PCNAc  
• PCNA expression in the mandibular condylar cartilage: 
 
Graph 
 
Notes (PCNAc by class) 
Output Created 2008-11-24T14:19:02.328
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data File 55
Syntax GRAPH 
  /SCATTERPLOT(BIVAR)=days WITH PCNAc BY class 
  /MISSING=LISTWISE. 
 
Resources Processor Time 0:00:00.297
Elapsed Time 0:00:00.297
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Explore 
 
Notes (PCNAc by days by appliance) 
Output Created 2008-09-23T13:35:58.570
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet1 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55
Missing Value 
Handling 
Definition of 
Missing 
User-defined missing values for dependent variables are 
treated as missing. 
Cases Used Statistics are based on cases with no missing values for any 
dependent variable or factor used. 
Syntax EXAMINE VARIABLES=PCNAc BY days BY appl 
  /PLOT=BOXPLOT 
  /STATISTICS=NONE 
  /NOTOTAL. 
 
Resources Processor Time 0:00:00.219
Elapsed Time 0:00:00.219
[DataSet1] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Days*appl 
PCNAc 
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XGraph 
 
Notes (PCNAc by days by appliance) 
Output Created 2008-09-23T13:36:52.913
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet1 
Filter <none>
Weight <none> 
Split File <none> 
N of Rows in 
Working Data File 55
Syntax XGRAPH CHART=[POINT] BY PCNAc[s] 
  /DISPLAY DOT=ASYMMETRIC 
  /PANEL COLVAR=appl COLOP=CROSS ROWVAR=days 
ROWOP=CROSS. 
 
Resources Processor Time 0:00:00.172
Elapsed Time 0:00:00.156
[DataSet1] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Univariate Analysis of Variance 
 
Notes (class-days) 
Output Created 2008-11-24T14:29:29.484
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA PCNAc BY days class WITH wts 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(days) WITH(wts=MEAN) 
COMPARE ADJ(BONFERRONI) 
  /EMMEANS=TABLES(class) WITH(wts=MEAN) 
COMPARE ADJ(BONFERRONI) 
  /EMMEANS=TABLES(class*days) WITH(wts=MEAN) 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=days class class*days wts. 
 
Resources Processor Time 0:00:00.015
Elapsed Time 0:00:00.032
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Notes (appliance-days) 
Output Created 2008-11-24T14:41:51.266
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA PCNAc BY days appl WITH wts 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(days) WITH(wts=MEAN) 
  /EMMEANS=TABLES(appl) WITH(wts=MEAN) 
  /EMMEANS=TABLES(appl*days) WITH(wts=MEAN) 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=days appl appl*days wts. 
 
Resources Processor Time 0:00:00.031
Elapsed Time 0:00:00.015
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Between-Subjects Factors (class-days)
  N 
days 3 14
14 14
21 13
30 10
class 0 20
2 12
3 19
 
Tests of Between-Subjects Effects (class-days) 
Dependent Variable:PCNAc     
Source Type III Sum of Squares df Mean Square F Sig.
Corrected Model 30519.090a 12 2543.257 4.022 .000
Intercept 1251.399 1 1251.399 1.979 .168
days 10177.782 3 3392.594 5.365 .004
class 1776.271 2 888.135 1.405 .258
days * class 3990.721 6 665.120 1.052 .408
wts 34.467 1 34.467 .055 .817
Error 24027.616 38 632.306   
Total 253953.000 51    
Corrected Total 54546.706 50    
a. R Squared = .560 (Adjusted R Squared = .420)   
 
 
Between-Subjects Factors (appliance-days)
  N 
days 3 14
14 14
21 15
30 10
appl 0 20
1 33
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Tests of Between-Subjects Effects (appliance-days) 
Dependent Variable:PCNAc     
Source Type III Sum of Squares df Mean Square F Sig.
Corrected Model 31053.936a 8 3881.742 6.405 .000
Intercept 665.863 1 665.863 1.099 .300
wts 11.293 1 11.293 .019 .892
days 10434.587 3 3478.196 5.739 .002
appl 1752.509 1 1752.509 2.892 .096
days * appl 2152.748 3 717.583 1.184 .327
Error 26667.385 44 606.077   
Total 274042.000 53    
Corrected Total 57721.321 52    
a. R Squared = .538 (Adjusted R Squared = .454)   
 
Estimated Marginal Means 
 
1. days 
 
Estimates
Dependent Variable:PCNAc   
days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
3 34.011a 19.706 -5.882 73.905
14 50.114a 6.877 36.193 64.035
21 94.805a 9.678 75.212 114.397
30 87.231a 15.768 55.311 119.151
a. Covariates appearing in the model are evaluated at the following values: wts = 149.471. 
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Pairwise Comparisons
Dependent Variable:PCNAc     
(I) days (J) days 
Mean Difference
(I-J) Std. Error Sig.a
95% Confidence Interval for Differencea
Lower Bound Upper Bound 
3 14 -16.103 21.967 1.000 -77.247 45.041
21 -60.793 26.854 .176 -135.540 13.954
30 -53.220 33.551 .726 -146.607 40.168
14 3 16.103 21.967 1.000 -45.041 77.247
21 -44.691* 11.154 .002 -75.738 -13.643
30 -37.117 16.190 .165 -82.182 7.948
21 3 60.793 26.854 .176 -13.954 135.540
14 44.691* 11.154 .002 13.643 75.738
30 7.574 13.039 1.000 -28.721 43.869
30 3 53.220 33.551 .726 -40.168 146.607
14 37.117 16.190 .165 -7.948 82.182
21 -7.574 13.039 1.000 -43.869 28.721
Based on estimated marginal means    
a. Adjustment for multiple comparisons: Bonferroni.  
*. The mean difference is significant at the .05 level.   
 
Univariate Tests
Dependent Variable:PCNAc    
 Sum of Squares df Mean Square F Sig. 
Contrast 10177.782 3 3392.594 5.365 .004
Error 24027.616 38 632.306   
The F tests the effect of days. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
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2. class 
Estimates
Dependent Variable:PCNAc   
class Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 57.322a 7.126 42.897 71.747
2 75.154a 7.513 59.944 90.363
3 67.145a 6.211 54.572 79.718
a. Covariates appearing in the model are evaluated at the following values: wts = 149.471. 
 
Pairwise Comparisons 
Dependent Variable:PCNAc     
(I) class (J) class 
Mean Difference
(I-J) Std. Error Sig.a
95% Confidence Interval for Differencea
Lower Bound Upper Bound 
0 2 -17.832 10.639 .306 -44.478 8.815
3 -9.823 10.224 1.000 -35.430 15.784
2 0 17.832 10.639 .306 -8.815 44.478
3 8.008 9.626 1.000 -16.101 32.118
3 0 
9.823 10.224 1.000 -15.784 35.430
2 -8.008 9.626 1.000 -32.118 16.101
Based on estimated marginal means    
a. Adjustment for multiple comparisons: Bonferroni.  
 
Univariate Tests
Dependent Variable:PCNAc    
 Sum of Squares df Mean Square F Sig. 
Contrast 1776.271 2 888.135 1.405 .258
Error 24027.616 38 632.306   
The F tests the effect of class. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
 
 
 
 
 
 
 
 
 
 
 
 
157 
 
3. class * days 
 
Dependent Variable:PCNAc   
class days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3 29.917a 19.373 -9.302 69.135
14 48.656a 11.591 25.191 72.121
21 91.355a 14.548 61.905 120.805
30 59.360a 24.038 10.698 108.023
2 3 36.529a 25.183 -14.451 87.509
14 46.144a 12.581 20.675 71.613
21 97.194a 15.924 64.958 129.430
30 1.207E2 21.321 77.584 163.910
3 3 35.588a 21.506 -7.948 79.124
14 55.542a 11.341 32.584 78.500
21 95.865a 11.840 71.896 119.835
30 81.585a 16.027 49.139 114.031
a. Covariates appearing in the model are evaluated at the following values: wts = 149.471. 
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4. appl 
 
Dependent Variable:PCNAc   
appl Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 55.758a 6.787 42.080 69.436
1 70.886a 4.669 61.476 80.295
a. Covariates appearing in the model are evaluated at the following values: wts = 149.811. 
 
5. appl * days 
 
Dependent Variable:PCNAc   
appl days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3 35.628a 18.489 -1.634 72.889
14 47.658a 11.291 24.902 70.414
21 88.040a 13.910 60.006 116.073
30 51.707a 22.590 6.181 97.234
1 3 42.941a 20.049 2.536 83.347
14 51.160a 8.219 34.597 67.724
21 95.344a 8.787 77.635 113.052
30 94.097a 13.658 66.570 121.623
a. Covariates appearing in the model are evaluated at the following values: wts = 149.811. 
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NPar Tests 
 
Notes 
Output Created 2008-09-23T13:47:05.413
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet1 
Filter days=3 (FILTER) 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
15
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics for each test are based on all cases with valid data 
for the variable(s) used in that test. 
Syntax NPAR TESTS 
  /M-W= PCNAc BY appl(0 1) 
  /MISSING ANALYSIS. 
 
Resources Processor Time 0:00:00.000
Elapsed Time 0:00:00.016
Number of 
Cases Allowed a 112347
a. Based on availability of 
workspace memory. 
 
[DataSet1] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
 
Mann-Whitney Test day 3 
 
Ranks
 appl N Mean Rank Sum of Ranks 
PCNAc 0 5 6.10 30.50
1 9 8.28 74.50
Total 14   
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Test Statistics b
 PCNAc 
Mann-Whitney U 15.500
Wilcoxon W 30.500
Z -.935
Asymp. Sig. (2-tailed) .350
Exact Sig. [2*(1-tailed Sig.)] .364a
a. Not corrected for ties. 
b. Grouping Variable: appl 
 
NPar Tests 
 
Notes 
Output Created 2008-09-23T13:47:34.273
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet1 
Filter days=14 (FILTER) 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
15
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics for each test are based on all cases with valid data 
for the variable(s) used in that test. 
Syntax NPAR TESTS 
  /M-W= PCNAc BY appl(0 1) 
  /MISSING ANALYSIS. 
 
Resources Processor Time 0:00:00.031
Elapsed Time 0:00:00.015
Number of 
Cases Allowed a 112347
a. Based on availability of workspace memory. 
[DataSet1] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Mann-Whitney Test day 14 
 
Ranks 
 appl N Mean Rank Sum of Ranks 
PCNAc 0 5 6.10 30.50
1 9 8.28 74.50
Total 14   
 
 
 
 
Test Statistics b 
 PCNAc 
Mann-Whitney U 15.500
Wilcoxon W 30.500
Z -.934
Asymp. Sig. (2-tailed) .350
Exact Sig. [2*(1-tailed Sig.)] .364a
a. Not corrected for ties. 
b. Grouping Variable: appl 
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NPar Tests 
 
Notes 
Output Created 2008-09-23T13:48:10.038
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet1 
Filter days=21 (FILTER) 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
15
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics for each test are based on all cases with valid data 
for the variable(s) used in that test. 
Syntax NPAR TESTS 
  /M-W= PCNAc BY appl(0 1) 
  /MISSING ANALYSIS. 
 
Resources Processor Time 0:00:00.000
Elapsed Time 0:00:00.000
Number of 
Cases Allowed a 112347
a. Based on availability of 
workspace memory. 
 
[DataSet1] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
 
Mann-Whitney Test day 21 
 
Ranks
 appl N Mean Rank Sum of Ranks 
PCNAc 0 5 7.30 36.50
1 10 8.35 83.50
Total 15   
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Test Statistics b
 PCNAc 
Mann-Whitney U 21.500
Wilcoxon W 36.500
Z -.429
Asymp. Sig. (2-tailed) .668
Exact Sig. [2*(1-tailed Sig.)] .679a
a. Not corrected for ties. 
b. Grouping Variable: appl 
 
NPar Tests 
 
Notes 
Output Created 2008-09-23T13:48:30.179
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet1 
Filter days=30 (FILTER) 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
10
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics for each test are based on all cases with valid data 
for the variable(s) used in that test. 
Syntax NPAR TESTS 
  /M-W= PCNAc BY appl(0 1) 
  /MISSING ANALYSIS. 
 
Resources Processor Time 0:00:00.016
Elapsed Time 0:00:00.015
Number of 
Cases Allowed a 112347
a. Based on availability of workspace memory. 
[DataSet1] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Mann-Whitney Test day 30 
 
Ranks 
 appl N Mean Rank Sum of Ranks 
PCNAc 0 5 3.00 15.00
1 5 8.00 40.00
Total 10   
 
Test Statistics b
 PCNAc 
Mann-Whitney U .000
Wilcoxon W 15.000
Z -2.611
Asymp. Sig. (2-tailed) .009
Exact Sig. [2*(1-tailed Sig.)] .008a
a. Not corrected for ties. 
b. Grouping Variable: appl 
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PCNAgf 
• PCNA expression in the glenoid fossa: 
 
Graph 
 
Notes
Output Created 2008-11-24T14:26:13.125
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data File 55
Syntax GRAPH 
  /SCATTERPLOT(BIVAR)=days WITH PCNAgf BY class 
  /MISSING=LISTWISE. 
 
Resources Processor Time 0:00:00.250
Elapsed Time 0:00:00.234
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Univariate Analysis of Variance 
 
Notes (class-days) 
Output Created 2008-11-24T14:31:35.547
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA PCNAgf BY days class WITH wts 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(days) WITH(wts=MEAN) 
COMPARE ADJ(BONFERRONI) 
  /EMMEANS=TABLES(class) WITH(wts=MEAN) 
COMPARE ADJ(BONFERRONI) 
  /EMMEANS=TABLES(class*days) WITH(wts=MEAN) 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=days class class*days wts. 
 
Resources Processor Time 0:00:00.032
Elapsed Time 0:00:00.015
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Notes (appliance-days) 
Output Created 2008-11-24T14:42:19.578
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset $DataSet 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA PCNAgf BY days appl WITH wts 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(days) WITH(wts=MEAN) 
  /EMMEANS=TABLES(appl) WITH(wts=MEAN) 
  /EMMEANS=TABLES(appl*days) WITH(wts=MEAN) 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=days appl appl*days wts. 
 
Resources Processor Time 0:00:00.032
Elapsed Time 0:00:00.016
[$DataSet] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Between-Subjects Factors (class-days)
  N 
Days 3 13
14 15
21 12
30 8
Class 0 17
2 12
3 19
 
Tests of Between-Subjects Effects (class-days) 
Dependent Variable: PCNAgf     
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 2411.362a 12 200.947 9.761 .000
Intercept 66.785 1 66.785 3.244 .080
days 224.572 3 74.857 3.636 .022
class 198.530 2 99.265 4.822 .014
days * class 373.161 6 62.194 3.021 .017
wts 12.629 1 12.629 .613 .439
Error 720.555 35 20.587   
Total 11192.000 48    
Corrected Total 3131.917 47    
a. R Squared = .770 (Adjusted R Squared = .691)   
 
Between-Subjects Factors (appliance-days)
  N 
Days 3 13
14 15
21 14
30 8
Appl 0 17
1 33
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Tests of Between-Subjects Effects (appliance-days) 
Dependent Variable: PCNAgf     
Source Type III Sum of Squares df Mean Square F Sig.
Corrected Model 2058.550a 8 257.319 9.719 .000
Intercept 45.694 1 45.694 1.726 .196
days 286.055 3 95.352 3.602 .021
appl 79.750 1 79.750 3.012 .090
days * appl 94.082 3 31.361 1.185 .327
wts 5.425 1 5.425 .205 .653
Error 1085.470 41 26.475   
Total 11413.000 50    
Corrected Total 3144.020 49    
a. R Squared = .655 (Adjusted R Squared = .587)   
 
Estimated Marginal Means 
 
1. days 
 
Estimates
Dependent Variable: PCNAgf   
days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
3 18.260a 4.103 9.930 26.590
14 15.412a 1.264 12.845 17.978
21 10.826a 1.980 6.806 14.846
30 5.772a 3.579 -1.494 13.038
a. Covariates appearing in the model are evaluated at the following values: wts = 146.958. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
171 
 
Pairwise Comparisons
Dependent Variable: PCNAgf     
(I) days (J) days 
Mean Difference
(I-J) Std. Error Sig.a
95% Confidence Interval for Differencea
Lower Bound Upper Bound 
3 14 2.848 4.670 1.000 -10.211 15.907
21 7.434 5.666 1.000 -8.412 23.280
30 12.488 7.377 .596 -8.142 33.117
14 3 -2.848 4.670 1.000 -15.907 10.211
21 4.586 2.063 .197 -1.183 10.354
30 9.640* 3.413 .047 .095 19.185
21 3 -7.434 5.666 1.000 -23.280 8.412
14 -4.586 2.063 .197 -10.354 1.183
30 5.054 2.727 .434 -2.573 12.681
30 3 -12.488 7.377 .596 -33.117 8.142
14 -9.640* 3.413 .047 -19.185 -.095
21 -5.054 2.727 .434 -12.681 2.573
Based on estimated marginal means    
a. Adjustment for multiple comparisons: Bonferroni.  
*. The mean difference is significant at the .05 level.   
 
Univariate Tests
Dependent Variable: PCNAgf    
 Sum of Squares Df Mean Square F Sig. 
Contrast 224.572 3 74.857 3.636 .022
Error 720.555 35 20.587   
The F tests the effect of days. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
172 
 
2. class 
 
Estimates 
Dependent Variable: PCNAgf   
class Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 9.878a 1.661 6.506 13.250
2 15.856a 1.351 13.113 18.599
3 11.969a 1.153 9.629 14.308
a. Covariates appearing in the model are evaluated at the following values: wts = 146.958. 
 
Pairwise Comparisons
Dependent Variable: PCNAgf     
(I) 
class 
(J) 
class 
Mean Difference (I-
J) 
Std. 
Error Sig.a
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
0 2 -5.978* 2.109 .023 -11.282 -.673
3 -2.091 2.243 1.000 -7.730 3.549
2 0 5.978* 2.109 .023 .673 11.282
3 3.887 1.788 .110 -.609 8.383
3 0 2.091 2.243 1.000 -3.549 7.730
2 -3.887 1.788 .110 -8.383 .609
Based on estimated marginal means    
*. The mean difference is significant at the .05 level.   
a. Adjustment for multiple comparisons: Bonferroni.  
 
Univariate Tests
Dependent Variable: PCNAgf    
 Sum of Squares df Mean Square F Sig. 
Contrast 198.530 2 99.265 4.822 .014
Error 720.555 35 20.587   
The F tests the effect of class. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
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3.  class * days 
Dependent Variable: PCNAgf   
class days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3 12.193a 3.976 4.122 20.264
14 14.431a 2.183 9.999 18.863
21 6.511a 2.982 .458 12.564
30 6.377a 5.789 -5.376 18.130
2 3 27.694a 4.967 17.610 37.779
14 14.831a 2.271 10.221 19.442
21 13.259a 3.073 7.019 19.498
30 7.638a 4.213 -.914 16.191
3 3 14.892a 4.572 5.610 24.175
14 16.973a 1.893 13.130 20.816
21 12.708a 2.343 7.952 17.464
30 3.301a 3.102 -2.996 9.598
a. Covariates appearing in the model are evaluated at the following values: wts = 146.958. 
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4. appl 
Dependent Variable: PCNAgf   
appl Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 9.484a 1.782 5.885 13.084
1 13.265a .964 11.317 15.212
a. Covariates appearing in the model are evaluated at the following values: wts = 147.420. 
 
5.  appl * days 
Dependent Variable: PCNAgf   
appl days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 3 13.180a 4.318 4.459 21.901
14 14.165a 2.438 9.241 19.090
21 5.821a 3.222 -.687 12.329
30 4.770a 6.149 -7.648 17.189
1 3 20.433a 4.763 10.813 30.053
14 16.014a 1.646 12.689 19.339
21 12.236a 1.992 8.214 16.259
30 4.375a 3.153 -1.991 10.742
a. Covariates appearing in the model are evaluated at the following values: wts = 147.420. 
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Weight 
• Rats weight at four weeks of age (wt4, beginning of the study) and at the day of 
sacrifice (wts): 
 
Graph 
 
Notes
Output Created 2008-09-10T11:04:59.453
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet0 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data File 55
Syntax GRAPH 
  /SCATTERPLOT(BIVAR)=days WITH wts BY appl 
  /MISSING=LISTWISE. 
 
Resources Processor Time 0:00:00.234
Elapsed Time 0:00:00.235
[DataSet0] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Univariate Analysis of Variance 
 
Notes (class-days) 
Output Created 2008-09-10T11:16:32.968
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet0 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA wts BY days class WITH wt4 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(days) WITH(wt4=MEAN) 
  /EMMEANS=TABLES(class) WITH(wt4=MEAN) 
  /EMMEANS=TABLES(days*class) WITH(wt4=MEAN)
  /PLOT=RESIDUALS 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=wt4 days class days*class. 
 
Resources Processor Time 0:00:00.235
Elapsed Time 0:00:00.202
[DataSet0] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Notes (appliance-days) 
Output Created 2008-09-10T11:08:07.734
Comments  
Input Data D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
Active Dataset DataSet0 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in 
Working Data 
File 
55
Missing Value 
Handling 
Definition of 
Missing User-defined missing values are treated as missing. 
Cases Used Statistics are based on all cases with valid data for all 
variables in the model. 
Syntax UNIANOVA wts BY days appl WITH wt4 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /EMMEANS=TABLES(days) WITH(wt4=MEAN) 
  /EMMEANS=TABLES(appl) WITH(wt4=MEAN) 
  /EMMEANS=TABLES(days*appl) WITH(wt4=MEAN) 
  /PLOT=RESIDUALS 
  /CRITERIA=ALPHA(.05) 
  /DESIGN=wt4 days appl days*appl. 
 
Resources Processor Time 0:00:00.265
Elapsed Time 0:00:00.219
[DataSet0] D:\Documents and Settings\ppetocz\My 
Documents\Data\SPSSdata\Consult\Zoe1.sav 
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Between-Subjects Factors (class-days)
  N 
Days 3 15
14 14
21 12
30 10
Class 0 18
2 12
3 21
 
Tests of Between-Subjects Effects (class-days) 
Dependent Variable: wts     
Source Type III Sum of Squares df Mean Square F Sig.
Corrected Model 61309.520a 12 5109.127 45.711 .000
Intercept 968.288 1 968.288 8.663 .006
wt4 549.070 1 549.070 4.913 .033
days 36150.597 3 12050.199 107.813 .000
class 3319.610 2 1659.805 14.850 .000
days * class 1588.671 6 264.778 2.369 .048
Error 4247.225 38 111.769   
Total 1174978.000 51    
Corrected Total 65556.745 50    
a. R Squared = .935 (Adjusted R Squared = .915)   
 
Between-Subjects Factors (appliance-days)
 N
Days 3 15
14 14
21 14
30 10
Appl 0 18
1 35
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Tests of Between-Subjects Effects (appliance-days) 
Dependent Variable: wts     
Source Type III Sum of Squares df Mean Square F Sig.
Corrected Model 61077.961a 8 7634.745 71.223 .000
Intercept 1331.025 1 1331.025 12.417 .001
wt4 471.082 1 471.082 4.395 .042
days 40292.009 3 13430.670 125.292 .000
appl 3196.598 1 3196.598 29.820 .000
days * appl 1216.944 3 405.648 3.784 .017
Error 4716.568 44 107.195   
Total 1225227.000 53    
Corrected Total 65794.528 52    
a. R Squared = .928 (Adjusted R Squared = .915)   
 
 
Estimated Marginal Means 
 
1. days 
 
Dependent Variable: wts   
days Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
3 102.16a 3.151 95.779 108.536
14 150.76a 2.967 144.753 156.765
21 166.80a 3.121 160.479 173.115
30 183.64a 3.636 176.282 191.003
a. Covariates appearing in the model are evaluated at the following values: wt4 = 91.473. 
 
2. class 
 
Dependent Variable: wts   
class Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 161.70a 2.513 156.612 166.786
2 148.01a 3.150 141.630 154.383
3 142.81a 2.476 137.799 147.824
a. Covariates appearing in the model are evaluated at the following values: wt4 = 91.473. 
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Pairwise Comparisons
Dependent Variable: wts     
(I) class (J) class 
Mean Difference
(I-J) Std. Error Sig.a
95% Confidence Interval for Differencea
Lower Bound Upper Bound 
0 2 13.693* 4.023 .005 3.617 23.768
3 18.888* 3.550 .000 9.996 27.780
2 0 -13.693* 4.023 .005 -23.768 -3.617
3 5.195 4.027 .614 -4.890 15.281
3 0 -18.888* 3.550 .000 -27.780 -9.996
2 -5.195 4.027 .614 -15.281 4.890
Based on estimated marginal means    
*. The mean difference is significant at the .05 level.   
a. Adjustment for multiple comparisons: Bonferroni.  
 
3. days * class 
Dependent Variable: wts    
days class Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
3 0 110.09a 4.905 100.164 120.023
2 96.48a 6.180 83.971 108.993
3 99.90a 4.246 91.301 108.492
14 0 154.72a 5.385 143.816 165.620
2 148.76a 5.291 138.050 159.472
3 148.80a 4.528 139.631 157.964
21 0 176.06a 5.319 165.289 186.824
2 167.64a 6.111 155.270 180.011
3 156.69a 4.883 146.809 166.579
30 0 205.93a 4.733 196.347 215.509
2 179.14a 7.522 163.914 194.371
3 165.86a 6.158 153.390 178.323
a. Covariates appearing in the model are evaluated at the following values: wt4 = 91.473. 
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4.  appl 
Dependent Variable: wts   
appl Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
0 161.67a 2.46 156.71 166.63
1 144.84a 1.84 141.13 148.55
a. Covariates appearing in the model are evaluated at the following values: wt4 = 91.489. 
 
5. days * appl 
Dependent Variable: wts    
days appl Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
3 0 109.76a 4.79 100.11 119.42
1 98.55a 3.49 91.51 105.58
14 0 155.00a 5.26 144.39 165.61
1 148.98a 3.34 142.25 155.72
21 0 175.91a 5.21 165.42 186.41
1 160.43a 3.31 153.75 167.11
30 0 205.99a 4.63 196.65 215.33
1 171.40a 4.69 161.94 180.85
a. Covariates appearing in the model are evaluated at the following values: wt4 = 91.489. 
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Appendix 3: Progressive report  
 A summarised progressive report of the project; 
2007 February-April  • Enrollment 
• Initial Settlements 
• Initial Research Topic Determination  and Literature Review 
2007 May-August  • Student Visa Procedure 
• Pilot Study 
− Key Points: 
Rat – Mice – Spheno Occipital Synchondrosis – 
Intermaxillary Suture – Micro Surgical Techniques - Tensile 
Force – Tissue Culture Media - Bone Remodeling 
2007 September- 
2008 April  
• Study Design:  
− Condylar Cartilage and Glenoid Fossa during Mandibular 
Advancement (A Histological and Biochemical Study) 
• Animal Ethics Approval and  Animal Welfare Course 
• 55 Rats arrival and Animal Laboratory Arrangements, Westmead 
• Animals and Experimental Design: 
− Providing Materials  
− Bite-Jumping Appliance  
− Euthanizing  
• Tissue Preparation: 
− Tissue Fixation in 4% Paraformaldehyde 
− Tissue Decalcification in 20% EDTA 
− TMJ Paraffin Embedding  
− Microtome Serial Sectioning 
2008 May-July • Immunohistochemical examinations: 
− Providing Materials and Facilities, and  Immunostaining  
Method Design at IDR, Westmead 
− Immunohistochemical Staining of the TMJ for Fibroblast 
Growth Factor 8 (FGF8) and Proliferating Cell Nuclear 
Antigen (PCNA) 
− Digital Microscopic Imaging 
− Stained Cells Counting  in the Condylar Cartilage and the 
Glenoid Fossa for FGF8 and PCNA 
2008 August-September • Initial Quantitative Statistical Analysis 
• Writing the Initial Draft of the Manuscript 
2008 October-December • Final Quantitative Statistical Analysis 
• Writing the Literature Review 
• Completion of the Manuscript and the Thesis 
• Accepted for Oral Presentation at AAO Annual Meeting in Boston-
USA May 2009
2009 January • Submitting the Manuscript to the American Journal of Orthodontics 
and Dentofacial Orthopedics (AJO-DO) 
• Submitting the Thesis to the University of Sydney. 
2009 May • Presented as an oral research abstract presentation at the 
American Association of Orthodontists (AAO) 109th Annual 
Session in Boston, Massachusetts - USA  
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